{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":130,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":130,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"af7a8fbc2407","filters":{"venue":"Expert Opinion on Investigational Drugs"}},"results":[{"id":"W2103567156","doi":"10.1517/13543784.15.8.933","title":"Cationic antimicrobial peptides as novel cytotoxic agents for cancer treatment","year":2006,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Antimicrobial Peptides and Activities","field":"Immunology and Microbiology","cited_by":432,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Dalhousie University","funders":"","keywords":"Cytotoxicity; Cancer cell; Lytic cycle; Cancer; Angiogenesis; Antimicrobial; Cancer research; Cytotoxic T cell; Apoptosis; Biology; Chemotherapy; Drug resistance; Drug; Pharmacology; Immunology; In vitro; Microbiology; Biochemistry","authors":[{"name":"Jamie S. Mader","is_ca":true},{"name":"David W. Hoskin","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08353260939165319,"gpt":0.3646609990887729,"spread":0.2811283896971197,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006341475,0.0009529436,0.001076633,0.001184913,0.0002470006,0.0006967653,0.0007727794,0.00126391,0.003152104],"category_scores_gemma":[0.0002296302,0.0002457239,0.0003157841,0.0008712917,0.0004718106,0.001236632,0.0004931046,0.00134542,0.002627881],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005652062,"about_ca_system_score_gemma":0.0004411608,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002977622,"about_ca_topic_score_gemma":0.0005450615,"domain_scores_codex":[0.9998376,0.00003651926,0.00001537946,0.00002475408,0.00006754073,0.00001812834],"domain_scores_gemma":[0.999903,0.00002596791,0.00001993426,0.000004612154,0.00002737921,0.0000191483],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001559057,0.0002051947,0.0001436414,0.006058489,0.00004672485,0.0009006188,0.0001025343,0.0009557214,0.05855431,0.006762912,0.01358423,0.9125297],"study_design_scores_gemma":[0.0001019052,0.0005333017,0.0005352879,0.0009583195,0.00004771956,0.002961116,0.00006173227,0.0003345742,0.01080375,0.002768897,0.9808636,0.00002986994],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001161325,0.993951,0.001061699,0.0003708408,0.0003293967,0.00002414881,0.00001480019,0.00002330613,0.003063566],"genre_scores_gemma":[0.006124043,0.9869978,0.002479696,0.0004593116,0.0004294856,0.00005231153,0.00005153898,0.000005464654,0.003400278],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003152104,"threshold_uncertainty_score":0.01054484,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2152775636","doi":"10.1517/13543784.12.4.663","title":"Pregabalin: a new anxiolytic","year":2003,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Neuroscience and Neuropharmacology Research","field":"Neuroscience","cited_by":316,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Dalhousie University","funders":"","keywords":"Pregabalin; Gabapentin; Anticonvulsant; Pharmacology; Anxiolytic; Neuropathic pain; Medicine; Epilepsy; Anesthesia; Anxiety; Psychiatry","authors":[{"name":"Bianca Lauria-Horner","is_ca":true},{"name":"Robert Pohl","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2469151906030161,"gpt":0.4506774258193225,"spread":0.2037622352163064,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004451797,0.000371894,0.0002124121,0.0002230883,0.0001371838,0.0001778346,0.0003102012,0.0002735743,0.003156281],"category_scores_gemma":[0.00004048822,0.00006503685,0.0001438917,0.0001351891,0.0001388837,0.0001886422,0.0001908057,0.0006109131,0.0009432997],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002162515,"about_ca_system_score_gemma":0.0001235222,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005097543,"about_ca_topic_score_gemma":0.001210145,"domain_scores_codex":[0.9999712,0.000003978716,0.000001960241,0.000006706893,0.000008345055,0.000007900367],"domain_scores_gemma":[0.9999858,0.000001545702,0.000003600781,7.700181e-7,0.000002420153,0.000005869075],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001276945,0.0007608213,0.0006647364,0.001493609,0.00005504606,0.001055522,0.00006700493,0.0004552852,0.6173869,0.002188625,0.005703206,0.3688924],"study_design_scores_gemma":[0.001586098,0.01043686,0.01742557,0.000332857,0.0002365088,0.01660615,0.0001030784,0.002379923,0.5298983,0.001035395,0.4198568,0.0001025029],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"review","genre_scores_codex":[0.5967465,0.2923704,0.02572013,0.003818549,0.001221344,0.0006104322,0.00215274,0.002049988,0.07530989],"genre_scores_gemma":[0.8409474,0.09876083,0.01539694,0.002762694,0.0003921406,0.0003295511,0.001898975,0.00006722626,0.03944422],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.003156281,"threshold_uncertainty_score":0.01055878,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2166753714","doi":"10.1517/13543780902832661","title":"Cathepsin K inhibitors for osteoporosis and potential off-target effects","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Bone Metabolism and Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":209,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institutes of Health; Canada Research Chairs","keywords":"Cathepsin K; Cathepsin; Osteoporosis; Medicine; Cathepsin A; Cancer research; Pharmacology; Chemistry; Biochemistry; Internal medicine; Osteoclast; Enzyme; In vitro","authors":[{"name":"Dieter Brömme","is_ca":true},{"name":"Fabien Lecaille","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01784050697919237,"gpt":0.3063636798781626,"spread":0.2885231728989702,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005478556,0.0008443129,0.001398896,0.001282407,0.0002719671,0.0006849354,0.0009366522,0.001461507,0.005204919],"category_scores_gemma":[0.000392784,0.0002952835,0.0005231365,0.001137786,0.0004324812,0.001036257,0.0005188682,0.001985301,0.00418931],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006440777,"about_ca_system_score_gemma":0.0006546904,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006292954,"about_ca_topic_score_gemma":0.002084467,"domain_scores_codex":[0.9998192,0.00003127607,0.00001791278,0.00002672093,0.00008255924,0.00002228856],"domain_scores_gemma":[0.99986,0.00004774249,0.00002630779,0.00000596233,0.00004239483,0.00001746247],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002094284,0.0002079751,0.0001130045,0.007762416,0.00008283966,0.0007002404,0.00006757437,0.0004921323,0.009831156,0.005101446,0.05128651,0.9241452],"study_design_scores_gemma":[0.00009891176,0.0002091799,0.0004033351,0.000945666,0.00005643772,0.001909597,0.00002729647,0.0001267894,0.001570044,0.001584883,0.9930497,0.00001804236],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0005046618,0.9947694,0.0003709965,0.0007585468,0.0003980056,0.0000174964,0.00003486145,0.00001992485,0.003125989],"genre_scores_gemma":[0.002096572,0.9933587,0.0005723731,0.0006112843,0.0002730802,0.00002250648,0.00006070287,0.00000385783,0.003000916],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.005204919,"threshold_uncertainty_score":0.01741219,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2112228502","doi":"10.1517/13543784.12.1.87","title":"Therapeutic potential of dipeptidyl peptidase IV inhibitors for the treatment of type 2 diabetes","year":2003,"lang":"en","type":"article","venue":"Expert Opinion on Investigational Drugs","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":208,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto General Hospital","funders":"","keywords":"Incretin; Dipeptidyl peptidase; Aminopeptidase; Peptide; Glucagon-like peptide-1; Dipeptidyl peptidase-4; Type 2 diabetes; Sitagliptin; Chemistry; Pharmacology; Biochemistry; Endocrinology; Internal medicine; Biology; Diabetes mellitus; Medicine; Enzyme; Amino acid","authors":[{"name":"Daniel J. Drucker","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02959327137273806,"gpt":0.2913622153120864,"spread":0.2617689439393484,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006219809,0.0004537976,0.0008047486,0.0004444526,0.0002164285,0.0007435973,0.0003890696,0.0008813366,0.003606349],"category_scores_gemma":[0.0002893412,0.0001163268,0.0003727471,0.0002105353,0.00028492,0.0004830829,0.0002464976,0.001181256,0.0009054065],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003199494,"about_ca_system_score_gemma":0.0003385249,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001809938,"about_ca_topic_score_gemma":0.0005706956,"domain_scores_codex":[0.9998538,0.00005838706,0.0000112059,0.00001532781,0.00004010661,0.00002111981],"domain_scores_gemma":[0.9999173,0.00003780796,0.00001431768,0.000003336208,0.00001400224,0.00001333499],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001279298,0.0004815974,0.0005902885,0.001969854,0.0001147521,0.001891839,0.00009993823,0.0008617762,0.05165763,0.01294403,0.01220208,0.9159068],"study_design_scores_gemma":[0.002747022,0.006316775,0.004751651,0.001505357,0.0005182042,0.01006556,0.0003195797,0.002232854,0.03203225,0.01780071,0.9216303,0.00007970356],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.02295434,0.9315499,0.005846643,0.01186133,0.001361071,0.0001110776,0.00008908504,0.00008825432,0.02613825],"genre_scores_gemma":[0.2059712,0.761682,0.01372381,0.004914982,0.001895165,0.0002103707,0.00016614,0.00002057301,0.01141571],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003606349,"threshold_uncertainty_score":0.01206446,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2017150135","doi":"10.1517/13543784.14.8.1019","title":"Angiotensin-(1-7) and its receptor as a potential targets for new cardiovascular drugs","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Renin-Angiotensin System Studies","field":"Medicine","cited_by":132,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"","keywords":"Angiotensin II receptor type 1; Renin–angiotensin system; Angiotensin II; Receptor; Angiotensin receptor; Angiotensin-converting enzyme; Pharmacology; Internal medicine; Biology; Chemistry; Endocrinology; Medicine; Blood pressure","authors":[{"name":"Robson A.S. Santos","is_ca":false},{"name":"Anderson J. Ferreira","is_ca":false},{"name":"Sérgio VB Pinheiro","is_ca":false},{"name":"Walkyria Oliveira Sampaio","is_ca":false},{"name":"Rhian M. Touyz","is_ca":true},{"name":"Maria José Campagnole‐Santos","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06479758894437689,"gpt":0.3517893935821556,"spread":0.2869918046377787,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007196901,0.0005696003,0.00153852,0.001259289,0.0002136436,0.0007125767,0.0007341481,0.001167363,0.005888123],"category_scores_gemma":[0.0004819043,0.0001953578,0.0003588584,0.001128375,0.0002995558,0.001230903,0.0003180441,0.001104983,0.003609359],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005478601,"about_ca_system_score_gemma":0.001056436,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007359662,"about_ca_topic_score_gemma":0.002338171,"domain_scores_codex":[0.999787,0.00006306473,0.00002480382,0.00002342289,0.00008315063,0.00001854825],"domain_scores_gemma":[0.9997665,0.0001028368,0.0000372838,0.000006587718,0.00006457729,0.00002220257],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002497654,0.000172586,0.0002456852,0.01516278,0.0001218027,0.001035619,0.00006723479,0.0002960461,0.004786624,0.004222542,0.03988977,0.9337494],"study_design_scores_gemma":[0.0001140071,0.0002993998,0.001225052,0.002897755,0.000179815,0.003057295,0.0001160175,0.0001227398,0.001030554,0.002530208,0.988407,0.00002014373],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001917382,0.9974543,0.0001003739,0.0005618618,0.0002356177,0.000006169161,0.00001111471,0.000004443239,0.001434234],"genre_scores_gemma":[0.001046262,0.9965639,0.0002818239,0.0004444839,0.0003490421,0.000009583854,0.00002295003,9.300721e-7,0.001281037],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.005888123,"threshold_uncertainty_score":0.01969779,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2152749001","doi":"10.1517/13543784.12.3.353","title":"Aromatase inhibitors for the treatment of infertility","year":2003,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Ovarian function and disorders","field":"Medicine","cited_by":120,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"","keywords":"Ovarian hyperstimulation syndrome; Ovulation induction; Infertility; Ovulation; Medicine; Aromatase; Follicular phase; Internal medicine; Endocrinology; Polycystic ovary; Letrozole; Anovulation; Pregnancy; Hormone; Biology; In vitro fertilisation; Insulin; Insulin resistance","authors":[{"name":"Mohamed FM Mitwally","is_ca":true},{"name":"Robert F. Casper","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1071983697560836,"gpt":0.3850609297580475,"spread":0.277862560001964,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003223707,0.000783898,0.0009982921,0.001738403,0.0002469026,0.0004613419,0.0006738909,0.000846759,0.007699428],"category_scores_gemma":[0.0004277737,0.0001586878,0.0004251056,0.001747753,0.0003150128,0.0006755498,0.0003648319,0.001173563,0.005307015],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004271865,"about_ca_system_score_gemma":0.0006455727,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001094054,"about_ca_topic_score_gemma":0.002705042,"domain_scores_codex":[0.9998261,0.0000311676,0.00002116049,0.00002386351,0.00008032333,0.00001728331],"domain_scores_gemma":[0.9998306,0.00006720076,0.00003356033,0.000007072244,0.00004168335,0.00001975188],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001012319,0.0001024594,0.0002198636,0.007409485,0.00006917067,0.0009155182,0.00004757518,0.0001851147,0.002391563,0.001412067,0.04777574,0.9393702],"study_design_scores_gemma":[0.00006702492,0.0001141156,0.001272946,0.00159056,0.00007326397,0.005143296,0.00003877677,0.00005253997,0.0005460944,0.0009737915,0.9901167,0.00001093649],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001811252,0.9952426,0.0001442044,0.0003402899,0.0003212857,0.000008782208,0.00001577567,0.00001005328,0.00373595],"genre_scores_gemma":[0.001658733,0.993437,0.0002977726,0.0004307859,0.0003960011,0.00001111879,0.00004809801,0.00000270776,0.00371777],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.007699428,"threshold_uncertainty_score":0.02575713,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2054297512","doi":"10.1517/13543780902980171","title":"Sunitinib in solid tumors","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Gastrointestinal Tumor Research and Treatment","field":"Medicine","cited_by":119,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Sunitinib; GiST; Medicine; Sorafenib; Everolimus; Renal cell carcinoma; Imatinib; Tyrosine-kinase inhibitor; Bevacizumab; Oncology; Pharmacology; Internal medicine; Cancer; Stromal cell; Hepatocellular carcinoma; Chemotherapy","authors":[{"name":"Hui Gan","is_ca":true},{"name":"Boštjan Šeruga","is_ca":true},{"name":"Jennifer J. Knox","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1198872661313079,"gpt":0.4374837508832138,"spread":0.3175964847519059,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004129416,0.0005954442,0.001250586,0.001947613,0.0002450335,0.0007163205,0.000591518,0.000856648,0.007618927],"category_scores_gemma":[0.0004971443,0.0001591016,0.0004992599,0.001660109,0.0002893536,0.0007989496,0.0004477369,0.0009803645,0.004217304],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006226137,"about_ca_system_score_gemma":0.0008753559,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001026199,"about_ca_topic_score_gemma":0.001791087,"domain_scores_codex":[0.9998072,0.00003688074,0.00003357382,0.00003750077,0.00006966005,0.00001523267],"domain_scores_gemma":[0.9997843,0.00009088088,0.00004691429,0.000008995199,0.00004933,0.00001955268],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006843887,0.00003572551,0.0001471753,0.0108721,0.00007827675,0.0003366548,0.00003123868,0.0002325301,0.001015761,0.001391802,0.0307657,0.9550247],"study_design_scores_gemma":[0.00004097702,0.0001064069,0.0009311178,0.002484971,0.000121201,0.003899458,0.00002849518,0.00007998509,0.0007600298,0.001104088,0.990431,0.00001225388],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001368078,0.9974048,0.00006560874,0.0001757934,0.0002352954,0.00000378092,0.00001301782,0.000008397799,0.001956561],"genre_scores_gemma":[0.002593419,0.9943151,0.000221781,0.0003118184,0.0004383779,0.000009220871,0.00006749245,0.000003268916,0.002039533],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.007618927,"threshold_uncertainty_score":0.0254879,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1970919362","doi":"10.1517/13543784.11.8.1061","title":"Cytokine modulation in sepsis and septic shock","year":2002,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Macrophage Migration Inhibitory Factor","field":"Immunology and Microbiology","cited_by":113,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba","funders":"","keywords":"Sepsis; Medicine; Septic shock; Cytokine; Proinflammatory cytokine; Tumor necrosis factor alpha; Immunology; Inflammation","authors":[{"name":"Sergio Zanotti","is_ca":false},{"name":"Anand Kumar","is_ca":true},{"name":"Aseem Kumar","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05579661714413267,"gpt":0.3200596065372179,"spread":0.2642629893930852,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002897095,0.00066855,0.001025019,0.0009358302,0.0002451083,0.0006365057,0.000486001,0.0009389624,0.002245933],"category_scores_gemma":[0.0002931844,0.0001408589,0.0002441197,0.001097371,0.000308267,0.0006778328,0.0003407524,0.0009338818,0.001939308],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003828472,"about_ca_system_score_gemma":0.0005661746,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000492907,"about_ca_topic_score_gemma":0.001059814,"domain_scores_codex":[0.999864,0.00003218626,0.00001779707,0.00001977273,0.00005266491,0.00001364294],"domain_scores_gemma":[0.9999027,0.00003053709,0.00001736689,0.00000335217,0.0000335935,0.0000123634],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001861749,0.0001203535,0.0002567765,0.01008849,0.00005321424,0.0006135203,0.0000718564,0.0002468118,0.009077157,0.002220862,0.02049347,0.9565713],"study_design_scores_gemma":[0.00005951826,0.0003891107,0.002161954,0.002123185,0.00009175435,0.004217459,0.0001001804,0.0001290107,0.003045909,0.002512455,0.9851481,0.00002137207],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000325175,0.9980249,0.0001015843,0.0002084767,0.0003266112,0.000004854523,0.000006513744,0.000004100276,0.0009977259],"genre_scores_gemma":[0.002216251,0.9954517,0.0002252022,0.0003177556,0.0003454699,0.00001072838,0.0000194096,0.000001193058,0.001412258],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002245933,"threshold_uncertainty_score":0.007513404,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2003487329","doi":"10.1517/13543784.16.4.519","title":"Vernakalant (RSD1235): a novel, atrial-selective antifibrillatory agent","year":2007,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Cardiac electrophysiology and arrhythmias","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research; Cardiome Pharma Corp.","keywords":"Medicine; Atrial fibrillation; Cardiology; Sinus rhythm; Internal medicine; Exacerbation; Ranolazine; Anti-Arrhythmia Agents","authors":[{"name":"David Fedida","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08118196522207384,"gpt":0.3816794494545254,"spread":0.3004974842324515,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002610972,0.0007038524,0.0008932125,0.001220067,0.0001985108,0.0005044061,0.0005096751,0.0008483119,0.002133841],"category_scores_gemma":[0.0002275459,0.0001443899,0.0003227696,0.0007477133,0.0002178556,0.0006368172,0.0002475688,0.000828657,0.001971807],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002735821,"about_ca_system_score_gemma":0.0003360544,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004166269,"about_ca_topic_score_gemma":0.0009910276,"domain_scores_codex":[0.9998969,0.00001471703,0.00001498859,0.00001979985,0.0000420002,0.00001165312],"domain_scores_gemma":[0.9999354,0.00002362521,0.00001575182,0.000001980181,0.0000140695,0.000009260416],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001306495,0.0001090814,0.0001482317,0.006249359,0.00005566384,0.001071462,0.00004582513,0.0002722747,0.01291001,0.001156034,0.01279172,0.9650598],"study_design_scores_gemma":[0.0001253671,0.0005544976,0.001543246,0.001006509,0.0001227843,0.009970963,0.00005046113,0.0002106909,0.005464109,0.0007252805,0.9801936,0.00003256527],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001674402,0.9932969,0.0006169452,0.0003689758,0.0003608703,0.00002031889,0.00003479488,0.00003088588,0.003595785],"genre_scores_gemma":[0.005882438,0.9891746,0.001066427,0.0004809435,0.0003635811,0.00002655794,0.0001056551,0.000004358785,0.002895443],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002133841,"threshold_uncertainty_score":0.007138431,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2103370158","doi":"10.1517/13543784.13.3.199","title":"Recent advances in protein tyrosine phosphatase 1B inhibitors","year":2004,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":83,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Waterloo","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Downregulation and upregulation; Leptin; Insulin resistance; Protein tyrosine phosphatase; Insulin; Type 2 diabetes; Diabetes mellitus; Obesity; Insulin receptor; Biology; Phosphatase; Tyrosine; Internal medicine; Endocrinology; Medicine; Cell biology; Biochemistry; Phosphorylation","authors":[{"name":"Scott D. Taylor","is_ca":true},{"name":"Bryan Hill","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02731105292417839,"gpt":0.3292266025047831,"spread":0.3019155495806047,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007420396,0.001180057,0.001413537,0.001661103,0.0003029151,0.0009155933,0.0008972748,0.001321343,0.005188487],"category_scores_gemma":[0.0006501999,0.000394431,0.0004958065,0.001755279,0.0004409111,0.001384773,0.0007013063,0.002168631,0.004827419],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000839508,"about_ca_system_score_gemma":0.0007134176,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007709313,"about_ca_topic_score_gemma":0.001981966,"domain_scores_codex":[0.9997031,0.00004511363,0.00003440033,0.00006174423,0.0001254785,0.00003005531],"domain_scores_gemma":[0.9997302,0.0001041645,0.00003917038,0.0000110771,0.00007473121,0.00004067629],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001767284,0.0001509448,0.0001038723,0.008802612,0.0000791057,0.0004957087,0.0000580657,0.000549343,0.007011465,0.004506927,0.05045918,0.927606],"study_design_scores_gemma":[0.00004369096,0.0001305311,0.000308507,0.0005767852,0.00005970224,0.0009994736,0.00001838889,0.00008990695,0.0009355377,0.000944265,0.9958801,0.0000131065],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002230453,0.9960508,0.0003689489,0.000538209,0.000599377,0.000008949489,0.00002029374,0.00001899887,0.002171402],"genre_scores_gemma":[0.0009542914,0.9949073,0.0005472684,0.0006994624,0.0005049066,0.00001503331,0.00004872468,0.000003525267,0.002319479],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.005188487,"threshold_uncertainty_score":0.01735723,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2116152202","doi":"10.1517/13543784.11.7.991","title":"Bosentan: a dual endothelin receptor antagonist","year":2002,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Pulmonary Hypertension Research and Treatments","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Bosentan; Endothelin receptor antagonist; Medicine; Endothelin receptor; Pulmonary hypertension; Tolerability; Internal medicine; Cardiology; Pharmacology; Receptor; Adverse effect","authors":[{"name":"Sébastiên Roux","is_ca":false},{"name":"Lewis J. Rubin","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.109545352175218,"gpt":0.3838684803300484,"spread":0.2743231281548305,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003456944,0.000673965,0.0009787664,0.0009974607,0.0002135198,0.0005519828,0.0005940109,0.0009086044,0.003838322],"category_scores_gemma":[0.0002326993,0.0001448901,0.0003353778,0.0008794089,0.0002208808,0.0006957153,0.0002585087,0.001159543,0.00350629],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003593001,"about_ca_system_score_gemma":0.0004935168,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004977071,"about_ca_topic_score_gemma":0.001224792,"domain_scores_codex":[0.9998646,0.00002692431,0.00001494734,0.00002225217,0.00005733847,0.00001400337],"domain_scores_gemma":[0.999933,0.00001851974,0.00001632196,0.000002226954,0.00001750657,0.00001236749],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002490121,0.0001899004,0.0001824441,0.006139902,0.00007885485,0.0006506139,0.00003472098,0.0001837355,0.00731484,0.001120905,0.02397225,0.9598829],"study_design_scores_gemma":[0.0002622417,0.0004949811,0.0018188,0.0008972901,0.0001242202,0.005020253,0.00003020645,0.0001325088,0.002831973,0.0006827538,0.987685,0.00001982802],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000766356,0.9947056,0.000317845,0.000466844,0.0004062811,0.00001866796,0.00003288302,0.00001946606,0.00326615],"genre_scores_gemma":[0.005233788,0.9864159,0.000799012,0.0009416893,0.000455815,0.00003119397,0.0001178403,0.00000338225,0.006001463],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003838322,"threshold_uncertainty_score":0.01284051,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2047925472","doi":"10.1517/13543780903282759","title":"Darinaparsin: a novel organic arsenical with promising anticancer activity","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":76,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; Jewish General Hospital","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Arsenic trioxide; Acute promyelocytic leukemia; In vivo; Cancer research; Arsenic; Pharmacology; Broad spectrum; Leukemia; In vitro; Chemistry; Medicine; Biology; Biochemistry; Immunology; Retinoic acid; Combinatorial chemistry","authors":[{"name":"Koren K. Mann","is_ca":true},{"name":"Barbara Wallner","is_ca":false},{"name":"Izidore S. Lossos","is_ca":false},{"name":"Wilson H. Miller","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04489331870199863,"gpt":0.3385623228525425,"spread":0.2936690041505439,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002629998,0.0005273776,0.0007589466,0.0008958665,0.0001774515,0.0005091162,0.0004491966,0.0007381302,0.002845596],"category_scores_gemma":[0.0001330777,0.0001525813,0.000266361,0.0008061227,0.0002323791,0.0006078604,0.0002923183,0.0007853287,0.00278538],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004569346,"about_ca_system_score_gemma":0.000432762,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005268598,"about_ca_topic_score_gemma":0.00178049,"domain_scores_codex":[0.9999154,0.00001180968,0.000008753791,0.00001992866,0.00003429769,0.000009879656],"domain_scores_gemma":[0.9999487,0.000012852,0.00001210893,0.000002002171,0.00001593975,0.000008234406],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001690072,0.0001295601,0.000199765,0.008474732,0.0000696015,0.0008149017,0.00006678571,0.0005844167,0.05698331,0.003943513,0.015664,0.9129005],"study_design_scores_gemma":[0.00006991775,0.0003505599,0.0005300068,0.0005133542,0.00007192573,0.002494369,0.0000497583,0.0001735937,0.01303506,0.001271597,0.9814166,0.00002335214],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002205912,0.9900581,0.001114144,0.0007254483,0.0002896972,0.00002919531,0.00005725438,0.00004054712,0.005479743],"genre_scores_gemma":[0.00693644,0.9865357,0.001507541,0.0004081105,0.0001597365,0.00002117345,0.0001220404,0.0000049464,0.004304295],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002845596,"threshold_uncertainty_score":0.009519458,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4232214719","doi":"10.1517/13543784.9.7.1511","title":"Psoriatic arthritis","year":2000,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"","keywords":"Psoriatic arthritis; Medicine; Rheumatoid arthritis; Arthritis; Psoriasis; Dactylitis; Inflammatory arthritis; Immunology; Osteolysis; Cytokine; Pathogenesis; Dermatology; Enthesitis; Surgery","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.05957936896122606,"gpt":0.3699500060783316,"spread":0.3103706371171055,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007565918,0.0008909761,0.001701941,0.001320179,0.0009099264,0.002623419,0.0007661241,0.001913609,0.09341421],"category_scores_gemma":[0.002996275,0.0002966885,0.0007515498,0.001517078,0.0004540193,0.0008241373,0.001078087,0.001826019,0.049265],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005702844,"about_ca_system_score_gemma":0.001057148,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001023018,"about_ca_topic_score_gemma":0.001511791,"domain_scores_codex":[0.9983735,0.0003080795,0.0001304252,0.0002076234,0.000730984,0.0002492816],"domain_scores_gemma":[0.9987685,0.0002121865,0.0002495641,0.0000963089,0.0004241817,0.0002491435],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004195424,0.0001683988,0.002597055,0.004261773,0.000220201,0.001495374,0.0001247184,0.00009716173,0.006134124,0.006107392,0.4616745,0.5166998],"study_design_scores_gemma":[0.0001051266,0.0001423574,0.003549855,0.0009499895,0.00009405116,0.007482055,0.00008490852,0.00006581553,0.0008458577,0.002445451,0.984207,0.0000275272],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01141995,0.6192453,0.006263122,0.01785759,0.01180592,0.0008441526,0.008990305,0.002156948,0.3214168],"genre_scores_gemma":[0.1998141,0.4877057,0.01060846,0.03513816,0.01084595,0.0008594108,0.0166384,0.0003936561,0.2379961],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.09341421,"threshold_uncertainty_score":0.3125017,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2150692587","doi":"10.1517/13543784.2013.769957","title":"5-Hydroxytryptamine 2A receptor antagonists as potential treatment for psychiatric disorders","year":2013,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Obsessive-Compulsive Spectrum Disorders","field":"Psychology","cited_by":63,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Toronto Western Hospital","funders":"","keywords":"Schizophrenia (object-oriented programming); Psychiatry; Antipsychotic; Psychosis; Anxiety; Mood disorders; Dementia; Psychology; Management of schizophrenia; Depression (economics); 5-HT2A receptor; Medicine; Disease; Serotonin; 5-HT receptor; Internal medicine","authors":[{"name":"Tiago Mestre","is_ca":true},{"name":"Mateusz Zurowski","is_ca":true},{"name":"Susan H. Fox","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03747977311721774,"gpt":0.3762715629305328,"spread":0.3387917898133151,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003063318,0.0003977948,0.0008428579,0.0007915002,0.0001318624,0.000491292,0.0003776318,0.0007094902,0.006392229],"category_scores_gemma":[0.0003718357,0.00008270574,0.000468385,0.0005760408,0.000172387,0.0004165324,0.000233159,0.001035298,0.001249694],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002686365,"about_ca_system_score_gemma":0.0003283763,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000326475,"about_ca_topic_score_gemma":0.002079824,"domain_scores_codex":[0.9998883,0.00003835345,0.00001778022,0.0000161584,0.00002882068,0.00001053748],"domain_scores_gemma":[0.9997982,0.00009404145,0.0000571453,0.000003004829,0.00003070701,0.00001693278],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005520295,0.0001624209,0.0003026736,0.02169545,0.0002094436,0.0005096677,0.00007181427,0.0002917267,0.003810895,0.002455046,0.02203551,0.9479033],"study_design_scores_gemma":[0.0007598649,0.002921956,0.007715083,0.01791538,0.00128253,0.005807079,0.0002548933,0.0004578817,0.002271445,0.003875036,0.9566781,0.00006062063],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0009007246,0.9962359,0.0001136226,0.0007307896,0.0002250475,0.00001507483,0.00004311523,0.00000955455,0.001726136],"genre_scores_gemma":[0.007970585,0.9888499,0.0003273897,0.0009724228,0.0004290675,0.00002395311,0.0000805434,0.000002790928,0.001343288],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.006392229,"threshold_uncertainty_score":0.02138418,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2095549754","doi":"10.1517/13543780903179294","title":"Emerging oligonucleotide therapies for asthma and chronic obstructive pulmonary disease","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Neonatal Respiratory Health Research","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Business Development Bank of Canada","funders":"","keywords":"Medicine; Asthma; COPD; Disease; Inflammation; Intensive care medicine; Immunology; Internal medicine","authors":[{"name":"Rosanne Séguin","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07718330351801966,"gpt":0.4155367821951554,"spread":0.3383534786771357,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006942879,0.0009454673,0.001435076,0.001763709,0.0003216527,0.0007116002,0.0008436418,0.001399793,0.005115088],"category_scores_gemma":[0.0004568523,0.0002560357,0.0005434966,0.001348614,0.0004588751,0.001264306,0.0005792644,0.002064259,0.003153221],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006094626,"about_ca_system_score_gemma":0.0008233649,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006790445,"about_ca_topic_score_gemma":0.001843079,"domain_scores_codex":[0.9997322,0.00005252645,0.00003063648,0.00004012847,0.0001202437,0.00002429233],"domain_scores_gemma":[0.999813,0.00007553378,0.00002953815,0.000006222343,0.00005550491,0.00002020208],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008427296,0.000178373,0.00009518128,0.009918879,0.00006395339,0.0003932222,0.00008132277,0.0002984096,0.007288979,0.005304436,0.02279113,0.9535019],"study_design_scores_gemma":[0.00004676189,0.0002021009,0.0004645606,0.001902516,0.00006317797,0.001516425,0.00005618543,0.00009610494,0.001129656,0.002171422,0.9923361,0.00001496007],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002463976,0.9960473,0.0003491311,0.0004288738,0.0004020477,0.00001531709,0.00001496907,0.0000114675,0.002484456],"genre_scores_gemma":[0.001087827,0.9954908,0.0008237437,0.0004453927,0.0002640165,0.00002313119,0.00003687382,0.000002080743,0.001826083],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.005115088,"threshold_uncertainty_score":0.01711166,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2079671777","doi":"10.1517/13543784.12.9.1471","title":"C-peptide and diabetic neuropathy","year":2003,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Advanced Glycation End Products research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":59,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Medical Research Council; Diabetes Canada; National Institutes of Health; Canadian Diabetes Association; American Diabetes Association","keywords":"Medicine; Diabetes mellitus; Insulin; Diabetic neuropathy; Type 2 diabetes; Internal medicine; Type 1 diabetes; Endocrinology; Animal studies; Bioinformatics; Biology","authors":[{"name":"Anders A. F. Sima","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05283565834488665,"gpt":0.3660591950859705,"spread":0.3132235367410838,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008375356,0.0006851625,0.0009062518,0.0004416024,0.0002207625,0.001218144,0.0008670073,0.003219973,0.007603746],"category_scores_gemma":[0.001090032,0.0001263154,0.0003848312,0.0004238575,0.0004760762,0.0008300316,0.0006269487,0.002552858,0.003500267],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006514253,"about_ca_system_score_gemma":0.0008822709,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007825136,"about_ca_topic_score_gemma":0.001040589,"domain_scores_codex":[0.9995607,0.0001200001,0.00003568141,0.0000701442,0.0001498535,0.00006368176],"domain_scores_gemma":[0.9994519,0.0001615357,0.0001138733,0.00001429363,0.0001725522,0.00008586103],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0007497457,0.0001513213,0.0008758041,0.008114748,0.0002227818,0.0009471087,0.00007502188,0.0004077677,0.004652563,0.009021134,0.2325591,0.7422229],"study_design_scores_gemma":[0.0002736248,0.000453049,0.002913499,0.003344988,0.0001642074,0.001982527,0.0001088488,0.0003456808,0.001209044,0.008495613,0.9806703,0.00003860195],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001030242,0.9693576,0.0004747438,0.01882301,0.004242728,0.00002033729,0.000113775,0.0000276836,0.005909924],"genre_scores_gemma":[0.01303202,0.9627507,0.0006262754,0.01028663,0.007611707,0.00004824965,0.000242759,0.00000825695,0.005393371],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.007603746,"threshold_uncertainty_score":0.025437,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4211244827","doi":"10.1517/13543784.11.2.189","title":"The macrolides","year":2002,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Saskatchewan; St. Paul's Hospital; Royal University Hospital","funders":"","keywords":"Clarithromycin; Azithromycin; Erythromycin; Medicine; Macrolide Antibiotics; Antimicrobial; Antibiotics; Intensive care medicine; Dosing; Adverse effect; Antibiotic resistance; Clinical trial; Pharmacology; Biology; Internal medicine; Microbiology","authors":[{"name":"Glen Hansen","is_ca":true},{"name":"K. Metzler","is_ca":true},{"name":"Emidio DeCarolis","is_ca":true},{"name":"Joseph M. Blondeau","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1025710305506434,"gpt":0.3915771278110502,"spread":0.2890060972604068,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000327289,0.001086003,0.001141398,0.001650412,0.0003208304,0.000906399,0.0007204312,0.001445299,0.004855191],"category_scores_gemma":[0.000617934,0.0002009745,0.0003809068,0.001187827,0.0005960052,0.0009913519,0.0007092028,0.001451907,0.005805553],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006635708,"about_ca_system_score_gemma":0.0007549141,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009500287,"about_ca_topic_score_gemma":0.001495464,"domain_scores_codex":[0.9995816,0.0000771239,0.00004734349,0.00008122758,0.0001784642,0.00003416749],"domain_scores_gemma":[0.9997833,0.00005485292,0.00005653264,0.0000152914,0.00005745259,0.00003254931],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001011407,0.00008608306,0.000257214,0.005409347,0.0000564806,0.0004252381,0.00006858167,0.0001944987,0.00609646,0.004695086,0.04258819,0.9400217],"study_design_scores_gemma":[0.00002249439,0.0000812166,0.0005695143,0.0008519902,0.00002352223,0.001838874,0.00001868235,0.00003244755,0.001394685,0.0008738614,0.9942843,0.000008305175],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0004129146,0.9908639,0.0006121443,0.0004922753,0.000377848,0.00001853285,0.00005226925,0.00003071854,0.007139405],"genre_scores_gemma":[0.004566235,0.9834934,0.001367093,0.001245883,0.0004596974,0.00004324175,0.0001387682,0.000006639608,0.008678962],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004855191,"threshold_uncertainty_score":0.01624221,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2056360850","doi":"10.1517/13543780802528609","title":"Custirsen (OGX-011): a second-generation antisense inhibitor of clusterin for the treatment of cancer","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Clusterin in disease pathology","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Clusterin; Prostate cancer; Cancer; Medicine; Clinical trial; Cancer research; Internal medicine; Oncology; Biology; Apoptosis; Biochemistry","authors":[{"name":"Kim N.","is_ca":true},{"name":"Amina Zoubeidi","is_ca":true},{"name":"Martin Gleave","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1531090493367765,"gpt":0.425771464691668,"spread":0.2726624153548915,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003510376,0.0006785945,0.0007560973,0.00119713,0.0001840355,0.0003852636,0.0006954929,0.0007128005,0.00275402],"category_scores_gemma":[0.0002096353,0.0001465175,0.0003359893,0.0009142116,0.0002243877,0.000507167,0.0002338628,0.0008703989,0.00219032],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005967395,"about_ca_system_score_gemma":0.0007403225,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001183499,"about_ca_topic_score_gemma":0.002629678,"domain_scores_codex":[0.9999045,0.0000133536,0.00001000844,0.00001924355,0.00004109308,0.00001170606],"domain_scores_gemma":[0.9999052,0.00002372348,0.00002385996,0.000002533757,0.00002818807,0.00001654732],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000234014,0.0001332505,0.0001683338,0.008259727,0.00009712401,0.0003159415,0.00003786898,0.0003063171,0.01071573,0.001190342,0.02846695,0.9500743],"study_design_scores_gemma":[0.0002068837,0.00053646,0.001414578,0.001172883,0.0001559234,0.003145999,0.00003979679,0.0001925807,0.006340603,0.0006096416,0.9861571,0.00002744734],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0009018477,0.9953604,0.0003791871,0.0003735622,0.0003080544,0.00002616703,0.00003525446,0.00002279944,0.002592729],"genre_scores_gemma":[0.00342443,0.9925673,0.0005436148,0.0003369886,0.0001935521,0.00002869242,0.0001314354,0.00000339538,0.002770641],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00275402,"threshold_uncertainty_score":0.00921315,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2129376177","doi":"10.1517/13543784.2014.998334","title":"Novel investigational drugs targeting IL-6 signaling for the treatment of depression","year":2015,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Tryptophan and brain disorders","field":"Neuroscience","cited_by":54,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Michael's Hospital; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Major depressive disorder; Antidepressant; Signal transduction; Neuroscience; Drug development; Medicine; Function (biology); Bioinformatics; Pharmacology; Drug; Psychology; Biology; Psychiatry; Cognition; Anxiety; Cell biology","authors":[{"name":"Trehani M. Fonseka","is_ca":true},{"name":"Roger S. McIntyre","is_ca":true},{"name":"Joanna K. Soczynska","is_ca":true},{"name":"Sidney H. Kennedy","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1507266465870713,"gpt":0.3748199668094526,"spread":0.2240933202223812,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002602959,0.0004440846,0.000700642,0.001036606,0.0001606795,0.0004696823,0.0005743136,0.0007575947,0.004827797],"category_scores_gemma":[0.0004007975,0.0001321256,0.0004451658,0.0007518746,0.0002380405,0.0005375315,0.0003963416,0.001308087,0.002168045],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003784968,"about_ca_system_score_gemma":0.0005508035,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005940296,"about_ca_topic_score_gemma":0.001824522,"domain_scores_codex":[0.9999019,0.00002085729,0.00001309673,0.00001829904,0.00003468007,0.00001119253],"domain_scores_gemma":[0.9998819,0.00004506304,0.00002480396,0.000003705736,0.00003366894,0.00001093672],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000109026,0.0000815048,0.000119903,0.01452842,0.0001030276,0.0002416465,0.00004357698,0.0003182833,0.004294685,0.003560272,0.02867948,0.9479201],"study_design_scores_gemma":[0.00005070818,0.0001912734,0.0007982559,0.003920001,0.000158559,0.001517626,0.00004151826,0.0001945238,0.001252434,0.002003069,0.9898534,0.00001858117],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003614481,0.9967239,0.0002779964,0.0005162325,0.000266207,0.0000126393,0.00004506446,0.00001193989,0.001784563],"genre_scores_gemma":[0.002045258,0.9957858,0.0003870821,0.0003617335,0.0001688501,0.00001429929,0.00005771465,0.00000213051,0.00117719],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004827797,"threshold_uncertainty_score":0.01615059,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1993494094","doi":"10.1517/13543784.16.10.1627","title":"Omega-3 fatty acid eicosapentaenoic acid. A new treatment for psychiatric and neurodegenerative diseases: a review of clinical investigations","year":2007,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Fatty Acid Research and Health","field":"Nursing","cited_by":52,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"The Scarborough Hospital; University of Toronto; University of Prince Edward Island","funders":"","keywords":"Eicosapentaenoic acid; Clinical trial; Schizophrenia (object-oriented programming); Disease; Medicine; Depression (economics); Neuroprotection; Omega 3 fatty acid; Psychiatry; Placebo; Polyunsaturated fatty acid; Internal medicine; Docosahexaenoic acid; Fatty acid; Biology; Alternative medicine; Pathology; Biochemistry","authors":[{"name":"Cai Song","is_ca":true},{"name":"Shannon X. Zhao","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2169775897946894,"gpt":0.4945456739486987,"spread":0.2775680841540094,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009788782,0.0008273642,0.002520002,0.00303196,0.0002927408,0.0008622897,0.0008991645,0.00106447,0.00483783],"category_scores_gemma":[0.001272688,0.0003055444,0.0007763322,0.003610098,0.000376479,0.001128108,0.000479329,0.001070525,0.002021426],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006086741,"about_ca_system_score_gemma":0.001602212,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001563981,"about_ca_topic_score_gemma":0.003969754,"domain_scores_codex":[0.9996871,0.00005952996,0.0000667319,0.00004779048,0.000122589,0.00001626123],"domain_scores_gemma":[0.9992687,0.0003722641,0.0001279002,0.00001424902,0.0001772495,0.00003962008],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001157024,0.00007171303,0.0002150204,0.05614336,0.0002257927,0.0002522783,0.00005461793,0.000143188,0.001036628,0.0008753649,0.0251195,0.9157467],"study_design_scores_gemma":[0.0001431209,0.0002859222,0.002678584,0.0399107,0.001033871,0.002778125,0.0002708839,0.0001150357,0.0006247604,0.002021779,0.950098,0.00003918661],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00004754432,0.9993705,0.00002968777,0.0001841547,0.00008190484,0.000004257561,0.00001044399,0.000001878975,0.000269534],"genre_scores_gemma":[0.0002532976,0.9992929,0.0001074219,0.000125742,0.0000581299,0.000005620648,0.00001157571,4.642947e-7,0.0001449214],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00483783,"threshold_uncertainty_score":0.01618421,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2100771859","doi":"10.1517/13543784.2015.1009629","title":"Investigational drugs for the treatment of spinal cord injury: review of preclinical studies and evaluation of clinical trials from Phase I to II","year":2015,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Spinal Cord Injury Research","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Toronto Western Hospital; University Health Network","funders":"AOSpine; Ontario Neurotrauma Foundation; European Commission; Acorda Therapeutics; Hadassah Medical Organization; Medtronic","keywords":"Medicine; Clinical trial; Riluzole; Spinal cord injury; Tolerability; Intensive care medicine; Neuroprotection; Pharmacology; Gabapentin; Adverse effect; Spinal cord; Disease; Internal medicine; Amyotrophic lateral sclerosis; Pathology; Alternative medicine","authors":[{"name":"Narihito Nagoshi","is_ca":true},{"name":"Michael G. Fehlings","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.7987099318314077,"gpt":0.7059770694690723,"spread":0.09273286236233536,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001667793,0.0009546467,0.002133207,0.002645442,0.0002291483,0.0009558225,0.001286495,0.001206034,0.00459113],"category_scores_gemma":[0.002251751,0.000339267,0.001239604,0.002609279,0.0005263665,0.001224228,0.000545981,0.001445235,0.001585401],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006076087,"about_ca_system_score_gemma":0.001934857,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009147069,"about_ca_topic_score_gemma":0.001782168,"domain_scores_codex":[0.9994224,0.0001373609,0.0001231818,0.00007985554,0.0002029397,0.00003423472],"domain_scores_gemma":[0.9986045,0.0007480338,0.0002501156,0.00003167859,0.0003205004,0.00004530139],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0001744768,0.00007925095,0.0001148875,0.09543233,0.0002826862,0.0001356025,0.00006623434,0.000254253,0.001415917,0.002083146,0.02357246,0.8763887],"study_design_scores_gemma":[0.0001531715,0.0004531216,0.001229023,0.06176943,0.001369902,0.001259751,0.0001164951,0.0001781232,0.001055784,0.002164238,0.9302096,0.00004132301],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00007038736,0.9989933,0.00008360093,0.0002408808,0.0001106269,0.00001637614,0.0000268142,0.00000462199,0.0004532631],"genre_scores_gemma":[0.000457175,0.9989208,0.0001538478,0.000207886,0.00007371903,0.00001578004,0.00002474625,0.000001185471,0.000144818],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00459113,"threshold_uncertainty_score":0.01535887,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2085430830","doi":"10.1517/13543784.11.12.1795","title":"Novel therapies for sepsis: antiendotoxin therapies","year":2002,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Immune Response and Inflammation","field":"Immunology and Microbiology","cited_by":49,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba; Health Sciences Centre; Manitoba Health","funders":"","keywords":"Sepsis; Lipopolysaccharide; Immune system; Lipid A; Monoclonal antibody; Immunology; Receptor; Septic shock; Biology; Antibody; Medicine; Internal medicine","authors":[{"name":"Sanjay Manocha","is_ca":true},{"name":"Daniel Feinstein","is_ca":false},{"name":"Aseem Kumar","is_ca":false},{"name":"Anand Kumar","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08159723834029357,"gpt":0.3380841695788234,"spread":0.2564869312385298,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005805538,0.001005983,0.001109451,0.001319629,0.000284952,0.000717094,0.0008666096,0.001512831,0.006907052],"category_scores_gemma":[0.0003698411,0.0001849843,0.0004166438,0.0008956071,0.0003960278,0.001101217,0.0004437342,0.001810634,0.004728944],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005149254,"about_ca_system_score_gemma":0.0005890275,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004111734,"about_ca_topic_score_gemma":0.001225622,"domain_scores_codex":[0.9997905,0.00004439823,0.00001876341,0.00002710809,0.0000986014,0.00002072454],"domain_scores_gemma":[0.9998466,0.00004940996,0.00002123293,0.00000706881,0.00005076842,0.00002488207],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001657722,0.0002605208,0.00009400214,0.004917351,0.00004830622,0.0005507221,0.00004637915,0.0002348742,0.007285673,0.002695981,0.03258072,0.9511195],"study_design_scores_gemma":[0.0001302704,0.0003710843,0.0006652946,0.001350809,0.00005541849,0.002538893,0.0000394872,0.0001228749,0.001418983,0.001788719,0.9915029,0.00001526563],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0004744096,0.9926023,0.0006216319,0.001149049,0.0009397154,0.00002744535,0.00001912609,0.00002313469,0.004143276],"genre_scores_gemma":[0.002023653,0.9891735,0.001217737,0.001327099,0.0009173029,0.00004308691,0.00005858277,0.000004028745,0.005235011],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.006907052,"threshold_uncertainty_score":0.0231064,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2107217435","doi":"10.1517/13543784.14.9.1129","title":"The therapeutic potential of NS3 protease inhibitors in HCV infection","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Hepatitis C virus research","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"","keywords":"NS3; Protease; Hepatitis C virus; Virology; Viral replication; Hepatitis C; Medicine; Drug discovery; Biology; Virus; Enzyme; Immunology; Bioinformatics; Biochemistry","authors":[{"name":"Nathalie Goudreau","is_ca":true},{"name":"Montse Llinàs‐Brunet","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08782441455950177,"gpt":0.4167827363426397,"spread":0.3289583217831379,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006571643,0.0008095595,0.001510117,0.001691632,0.0002897815,0.0008950658,0.0009323001,0.00121519,0.004634278],"category_scores_gemma":[0.0003082725,0.0002040198,0.000458196,0.001310407,0.0004278908,0.0009810798,0.0004887829,0.001384019,0.003440644],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005539115,"about_ca_system_score_gemma":0.0005469639,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007013649,"about_ca_topic_score_gemma":0.001625243,"domain_scores_codex":[0.9998275,0.00004043159,0.00001709288,0.00002250868,0.00007245422,0.00002002372],"domain_scores_gemma":[0.9998944,0.00003944735,0.00001871385,0.0000043625,0.00002815308,0.00001489834],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001903229,0.0001712664,0.000120294,0.008831567,0.00008017468,0.0007576124,0.00007649753,0.0004722799,0.007677431,0.003945422,0.02476687,0.9529102],"study_design_scores_gemma":[0.0001064504,0.0003822967,0.0008071397,0.001642931,0.00007170645,0.002239039,0.00005811314,0.0001597052,0.001490236,0.001748356,0.991272,0.00002193108],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0004845952,0.9955823,0.000194877,0.000426949,0.00026171,0.00001221116,0.00001970584,0.00001295507,0.003004681],"genre_scores_gemma":[0.002135653,0.9952345,0.000356202,0.0003678891,0.0002582619,0.00001611568,0.00003712874,0.000001965772,0.001592322],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004634278,"threshold_uncertainty_score":0.01550323,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2000370942","doi":"10.1517/13543784.9.9.2051","title":"Animal models in xenotransplantation","year":2000,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Xenotransplantation and immune response","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"London Health Sciences Centre","funders":"Medical Research Council; Physicians' Services Incorporated Foundation","keywords":"Xenotransplantation; Biology; Animal model; Computational biology; Transplantation; Medicine; Internal medicine; Endocrinology","authors":[{"name":"Zheng Zhang","is_ca":true},{"name":"Eric L.R. Bédard","is_ca":true},{"name":"Yigang Luo","is_ca":true},{"name":"Hao Wang","is_ca":true},{"name":"Shaoping Deng","is_ca":true},{"name":"David J. Kelvin","is_ca":true},{"name":"Robert Zhong","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.09810914091250716,"gpt":0.3836695085772858,"spread":0.2855603676647786,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003541149,0.001307083,0.001963397,0.002593465,0.0006034523,0.002334082,0.00190847,0.002895328,0.006075527],"category_scores_gemma":[0.001834892,0.0005729301,0.001286267,0.002498651,0.002007363,0.002263043,0.002324877,0.00568242,0.004259816],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008487425,"about_ca_system_score_gemma":0.001130441,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005935342,"about_ca_topic_score_gemma":0.0005813581,"domain_scores_codex":[0.9968592,0.001309208,0.000362648,0.0003002592,0.001003693,0.000165018],"domain_scores_gemma":[0.9986956,0.0005967326,0.0001883001,0.0002360988,0.0001670732,0.0001162826],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0007009198,0.0007770255,0.002272575,0.01742644,0.0003675348,0.002758004,0.000735753,0.003659851,0.1375652,0.1743717,0.0857846,0.5735806],"study_design_scores_gemma":[0.00004211053,0.0007982267,0.001322947,0.002418923,0.0001334872,0.005202744,0.0001259194,0.0008549128,0.01713382,0.02285081,0.9490444,0.00007168717],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.006233629,0.7606615,0.1679084,0.004914734,0.005609536,0.0009035822,0.001370901,0.0009826651,0.05141506],"genre_scores_gemma":[0.03475586,0.7902015,0.1432791,0.004818216,0.003417759,0.00199908,0.003739431,0.0003655663,0.01742348],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.006075527,"threshold_uncertainty_score":0.02032465,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1897302030","doi":"10.1517/13543784.2015.1051220","title":"Targeting of cancer stem cells by inhibitors of DNA and histone methylation","year":2015,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":45,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"China Scholarship Council","keywords":"Histone; DNA methylation; Epigenetics; Cancer; Biology; Cancer research; Cancer epigenetics; Cancer stem cell; Stem cell; DNA; Genetics; Histone methyltransferase; Computational biology; Gene; Gene expression","authors":[{"name":"Richard L. Momparler","is_ca":true},{"name":"Sylvie Côté","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04232140536129853,"gpt":0.3578750581984829,"spread":0.3155536528371844,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002449305,0.000348124,0.0003456367,0.0002317823,0.0001059598,0.0004402943,0.0003463426,0.0008447905,0.006418712],"category_scores_gemma":[0.0002728262,0.00008197856,0.0003438081,0.0001597703,0.0001755556,0.0003608899,0.0002485387,0.0008512979,0.002427741],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004397101,"about_ca_system_score_gemma":0.0003138569,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003531451,"about_ca_topic_score_gemma":0.0009010432,"domain_scores_codex":[0.99988,0.00001999786,0.000007322322,0.00002310788,0.00005077084,0.0000189178],"domain_scores_gemma":[0.9998846,0.00002010512,0.00003076906,0.000003452937,0.00004275296,0.00001828463],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0006924858,0.000149113,0.0009020269,0.008871167,0.0001789805,0.0004583866,0.00007313288,0.000931534,0.1118225,0.008094386,0.1346852,0.7331411],"study_design_scores_gemma":[0.0002261152,0.0008658728,0.001948789,0.0006983402,0.0001398178,0.001151384,0.00004966335,0.0007410053,0.04179693,0.00242034,0.949938,0.00002375703],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.02262924,0.905733,0.007395659,0.02484931,0.006873507,0.0002218021,0.001108089,0.0003748699,0.03081446],"genre_scores_gemma":[0.1445708,0.7900041,0.004743438,0.01347298,0.00600923,0.0002353945,0.001967325,0.00006040101,0.03893625],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.006418712,"threshold_uncertainty_score":0.02147269,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2122631980","doi":"10.1517/13543784.11.11.1605","title":"Selective phosphodiesterase type 5 inhibition using tadalafil for the treatment of erectile dysfunction","year":2002,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Sexual function and dysfunction studies","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St Joseph's Health Centre","funders":"","keywords":"Tadalafil; Erectile dysfunction; Sildenafil; Medicine; cGMP-specific phosphodiesterase type 5; Broad spectrum; Placebo; Population; Pharmacotherapy; Pharmacology; Internal medicine; Alternative medicine; Chemistry; Pathology","authors":[{"name":"James K. Kuan","is_ca":true},{"name":"Gerald Brock","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.211736959062446,"gpt":0.4044957225534691,"spread":0.1927587634910231,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006920825,0.0003311855,0.0005582639,0.0008785337,0.0001603324,0.000614219,0.000339834,0.0004392421,0.003775273],"category_scores_gemma":[0.0004212857,0.00009642231,0.0007272402,0.0006092059,0.0001835055,0.0003840381,0.000297146,0.0009892903,0.001346918],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002334826,"about_ca_system_score_gemma":0.0004021784,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004049552,"about_ca_topic_score_gemma":0.001504244,"domain_scores_codex":[0.9998254,0.00004695866,0.00002451865,0.00002565502,0.00005561237,0.00002178281],"domain_scores_gemma":[0.9998598,0.00004388653,0.0000427248,0.000006277938,0.00002904695,0.00001822996],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005156918,0.0002913016,0.0006303514,0.008869377,0.0002748464,0.0004876397,0.00008562707,0.000335541,0.03236935,0.002362359,0.01816293,0.935615],"study_design_scores_gemma":[0.0008712683,0.009433702,0.01356357,0.005733194,0.001168457,0.006312139,0.0001735574,0.0009995325,0.02434855,0.002681654,0.9346415,0.00007290693],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.008473019,0.9804212,0.001846053,0.001657161,0.0009691683,0.0000787134,0.00018096,0.00006360239,0.006310184],"genre_scores_gemma":[0.04782569,0.9413577,0.002907725,0.002084247,0.0008664302,0.00005730471,0.0004252285,0.00001504954,0.004460623],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003775273,"threshold_uncertainty_score":0.01262951,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2168406738","doi":"10.1517/13543784.10.12.2157","title":"Therapeutic potential of mycobacterial cell wall-DNA complexes","year":2001,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Mycobacterium research and diagnosis","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BioPhage Pharma (Canada)","funders":"","keywords":"Cell wall; Cell; Effector; Apoptosis; Biology; DNA; Cell division; Immune system; Mechanism of action; Cell growth; Mycobacterium; Cancer cell; Mycobacterium phlei; Cancer research; Microbiology; Cancer; Chemistry; Cell biology; Bacteria; Immunology; In vitro; Biochemistry; Genetics","authors":[{"name":"Nigel C. Phillips","is_ca":true},{"name":"Mario Filion","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07827342594698494,"gpt":0.3700735214891212,"spread":0.2918000955421363,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002283666,0.0004408104,0.0007099457,0.0007101826,0.0001753517,0.0004578337,0.0003940638,0.0007510952,0.001979686],"category_scores_gemma":[0.0001428782,0.000116345,0.0002207817,0.0005008677,0.0001799748,0.0003953245,0.0001831221,0.0004891211,0.001093491],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003393007,"about_ca_system_score_gemma":0.0003074522,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003748953,"about_ca_topic_score_gemma":0.0007513164,"domain_scores_codex":[0.9999075,0.00002111798,0.000008077746,0.0000150892,0.00003681317,0.00001140619],"domain_scores_gemma":[0.9999558,0.00001554855,0.00000911326,0.000002065367,0.00001196575,0.000005600366],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002231973,0.0001548303,0.000216558,0.008776317,0.00005735758,0.0009682305,0.0001042148,0.0004016917,0.07993441,0.003213512,0.006183366,0.8997664],"study_design_scores_gemma":[0.0001116228,0.0009821679,0.001706895,0.001242887,0.0001110244,0.004388494,0.00008515963,0.0002495489,0.03601266,0.001316578,0.9537719,0.00002109282],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002875253,0.9927072,0.00031741,0.0002124007,0.0001356945,0.00001146899,0.00001604483,0.000009472146,0.003715039],"genre_scores_gemma":[0.01750315,0.9775339,0.0008908014,0.0003538025,0.0001683098,0.00002494112,0.00006402806,0.000002224138,0.003458971],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.001979686,"threshold_uncertainty_score":0.006622672,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4230784343","doi":"10.1517/13543784.14.7.905","title":"Stiripentol","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Dravet syndrome; Medicine; Carbamazepine; Epilepsy; Felbamate; CYP2C19; Tolerability; Clobazam; Pharmacology; Myoclonic epilepsy; Orphan drug; Adjunctive treatment; Clinical trial; Pediatrics; Adverse effect; Internal medicine; Bioinformatics; Psychiatry","authors":[{"name":"Catherine Chiron","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1348169047952925,"gpt":0.4447422447116589,"spread":0.3099253399163664,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001163377,0.000727663,0.0004273692,0.000945565,0.0004028318,0.0005670168,0.0004405208,0.0006760365,0.02853349],"category_scores_gemma":[0.000222968,0.0001789725,0.0005964882,0.0003905657,0.0003045488,0.0004801686,0.0005528087,0.00136162,0.01154845],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004514212,"about_ca_system_score_gemma":0.0004931716,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007276952,"about_ca_topic_score_gemma":0.0009828677,"domain_scores_codex":[0.9997914,0.00002428353,0.00001230045,0.00005429709,0.00007148226,0.00004621804],"domain_scores_gemma":[0.99992,0.00001079317,0.00001433928,0.000007100315,0.00001879813,0.00002899265],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.005251302,0.001103485,0.001180838,0.00335302,0.0001502137,0.002569711,0.0001591227,0.0007955585,0.333107,0.008142786,0.0319509,0.612236],"study_design_scores_gemma":[0.0007524054,0.003689443,0.003848603,0.000340643,0.0001841313,0.006448001,0.0001128221,0.0005250583,0.2422496,0.001586558,0.7401817,0.00008098568],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"other","genre_gemma":"review","genre_scores_codex":[0.3390535,0.2172493,0.02987673,0.006081333,0.005082603,0.001597681,0.01307189,0.004846499,0.3831404],"genre_scores_gemma":[0.7169679,0.07957528,0.01262108,0.004291688,0.0007901391,0.0005236514,0.0116329,0.0004908046,0.1731065],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.02853349,"threshold_uncertainty_score":0.09545404,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2132420892","doi":"10.1517/13543784.17.5.619","title":"Osteoarthritic pain: a review of current, theoretical and emerging therapeutics","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Medicine; Chronic pain; Tolerability; Intensive care medicine; Osteoarthritis; Clinical trial; Population; Etiology; Bioinformatics; Alternative medicine; Physical therapy; Psychiatry; Pathology; Biology","authors":[{"name":"Simon Read","is_ca":false},{"name":"Andy Dray","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06397579900833963,"gpt":0.3767876863065986,"spread":0.3128118872982589,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001147716,0.00095636,0.001875403,0.003406813,0.0003766815,0.001421266,0.001162661,0.001349271,0.004141627],"category_scores_gemma":[0.001234225,0.0003669446,0.0006802295,0.003582819,0.0006925945,0.001903051,0.0005722637,0.001778901,0.002166885],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008599185,"about_ca_system_score_gemma":0.001581693,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001113665,"about_ca_topic_score_gemma":0.002489777,"domain_scores_codex":[0.9996222,0.00006659147,0.00006737026,0.00004937476,0.0001697135,0.0000247852],"domain_scores_gemma":[0.9992482,0.0004278347,0.00009443005,0.00001742554,0.0001606056,0.00005144242],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001083291,0.0001084928,0.0001747123,0.02413589,0.000103951,0.000352227,0.00008554661,0.0004382328,0.001505308,0.0029656,0.04475439,0.9252673],"study_design_scores_gemma":[0.00005056904,0.0001665814,0.0009780154,0.009158351,0.000156882,0.002092191,0.0001699878,0.0002136012,0.0003657997,0.00308125,0.9835364,0.0000303871],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00007817239,0.9985196,0.0001052946,0.0004458376,0.0002943658,0.000004589147,0.000009659959,0.000005293614,0.0005371923],"genre_scores_gemma":[0.0003164303,0.9986697,0.0002148337,0.0002245599,0.0002949654,0.000005962085,0.00001148985,8.55077e-7,0.0002612431],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004141627,"threshold_uncertainty_score":0.0138551,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2299867389","doi":"10.1517/13543784.2016.1142529","title":"Novel investigational therapies for onychomycosis: an update","year":2016,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Medicine; Terbinafine; Dermatology; Adverse effect; Azole; Pharmacology; Drug; Clinical trial; Investigational Drugs; Antifungal; Internal medicine; Itraconazole","authors":[{"name":"Aditya Gupta","is_ca":true},{"name":"Catherine Studholme","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1158912842742081,"gpt":0.4118034750595802,"spread":0.2959121907853721,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005064843,0.0006608725,0.001138872,0.002163479,0.000235377,0.0009267676,0.000781467,0.001085451,0.006667804],"category_scores_gemma":[0.0007846368,0.0002206125,0.0006696829,0.001897222,0.0003138974,0.001164919,0.0005384224,0.001700662,0.002430981],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004306562,"about_ca_system_score_gemma":0.0008983934,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007461634,"about_ca_topic_score_gemma":0.002012044,"domain_scores_codex":[0.9997674,0.00004168556,0.00004306991,0.00003200425,0.00009491539,0.00002105506],"domain_scores_gemma":[0.9995576,0.0001946926,0.0000763561,0.000009859858,0.0001288999,0.00003254242],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007478047,0.0000830862,0.0001235087,0.02222839,0.00008822729,0.0002894686,0.0000512164,0.0001664327,0.001233208,0.001486339,0.03482326,0.9393522],"study_design_scores_gemma":[0.00003063551,0.0001144048,0.0004903837,0.006377093,0.000186011,0.00171394,0.00005163807,0.00007714925,0.0002922197,0.0007053546,0.9899475,0.00001368318],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001216615,0.9981759,0.00008309402,0.0003452525,0.0002371165,0.000007485161,0.00002849123,0.000006329285,0.0009946636],"genre_scores_gemma":[0.0005271031,0.9982424,0.0002037585,0.0003040337,0.0001691789,0.000007685382,0.0000450756,0.000001426387,0.0004993071],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.006667804,"threshold_uncertainty_score":0.02230597,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2095646768","doi":"10.1517/13543784.12.10.1655","title":"Targeting cellular energy production in neurological disorders","year":2003,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Coenzyme Q10 studies and effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; McMaster University Medical Centre","funders":"","keywords":"Coenzyme Q10; Neuroprotection; Oxidative stress; Ataxia; Medicine; Amyotrophic lateral sclerosis; Creatine; Neuroscience; Disease; Excitotoxicity; Mitochondrial disease; Bioinformatics; Pharmacology; Biology; Pathology; Internal medicine; Biochemistry; Glutamate receptor","authors":[{"name":"Steven K. Baker","is_ca":true},{"name":"Mark A. Tarnopolsky","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02458881649965107,"gpt":0.2946587498849035,"spread":0.2700699333852525,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003464375,0.0008151322,0.001203693,0.001250649,0.0003300432,0.0007131824,0.0007680949,0.001272265,0.003709633],"category_scores_gemma":[0.0002060606,0.000201402,0.0002840052,0.00133665,0.0004740257,0.0009637291,0.0006567095,0.00117228,0.003478423],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007899164,"about_ca_system_score_gemma":0.0007384341,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001088041,"about_ca_topic_score_gemma":0.001910726,"domain_scores_codex":[0.9998857,0.00002021827,0.00001403713,0.00002040098,0.00004528258,0.0000143369],"domain_scores_gemma":[0.9999396,0.00001868046,0.000008958575,0.000003218008,0.00002142772,0.000008177219],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001244415,0.00009435548,0.0001045847,0.01024084,0.00005424832,0.0006256833,0.000106285,0.0005180624,0.0098418,0.008375132,0.02830127,0.9416133],"study_design_scores_gemma":[0.00002552587,0.00009397981,0.0004364114,0.001120584,0.00003721094,0.001672511,0.00006284722,0.00008163067,0.001388251,0.003174477,0.9918953,0.0000113097],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002816805,0.9954774,0.0004288247,0.000445508,0.0003659927,0.000008519068,0.00001152927,0.00001630777,0.002964261],"genre_scores_gemma":[0.001618778,0.9954922,0.0003846063,0.0002449794,0.0001643396,0.00001147262,0.00001916092,0.000002159976,0.002062146],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003709633,"threshold_uncertainty_score":0.01240999,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2047633734","doi":"10.1517/13543784.17.7.1029","title":"Heparin as an anticancer therapeutic","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Proteoglycans and glycosaminoglycans research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Hamilton Health Sciences","funders":"","keywords":"Heparin; Pharmacology; Intensive care medicine; Medicine; Anticancer drug; Drug; Internal medicine","authors":[{"name":"Leo R. Zacharski","is_ca":false},{"name":"Agnes YY Lee","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07779585488762812,"gpt":0.4086712590680824,"spread":0.3308754041804542,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004352659,0.0005695943,0.0008994018,0.00154499,0.0002166797,0.0006862774,0.0005040313,0.001238929,0.003225779],"category_scores_gemma":[0.0004232228,0.0001711245,0.000284788,0.001274823,0.0004284996,0.0008781592,0.0003862788,0.001449362,0.001826309],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006584329,"about_ca_system_score_gemma":0.0006257634,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007929164,"about_ca_topic_score_gemma":0.001233682,"domain_scores_codex":[0.9998355,0.00003909583,0.00002032649,0.0000307706,0.00006050645,0.00001372937],"domain_scores_gemma":[0.9998487,0.00007075391,0.00002117193,0.000005780543,0.00003971369,0.00001384138],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009383978,0.00008178133,0.0001832272,0.007516703,0.00006013895,0.0004466393,0.00005544362,0.0003178186,0.004292367,0.00725414,0.03458285,0.9451151],"study_design_scores_gemma":[0.00003131441,0.0001229044,0.0005018457,0.00152647,0.00006318485,0.002280986,0.00003201118,0.0001428044,0.001759815,0.001865055,0.991661,0.00001263598],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002020141,0.9969904,0.0001363364,0.0006100792,0.0002855936,0.000004970709,0.000008947576,0.000005582045,0.001755952],"genre_scores_gemma":[0.001911129,0.9957378,0.0002405088,0.0004533458,0.0003900711,0.000009952482,0.00002203685,0.000001260234,0.001233879],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003225779,"threshold_uncertainty_score":0.0107913,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2130413670","doi":"10.1517/13543784.9.5.1099","title":"Pharmacology and clinical assessment of cariporide for the treatment coronary artery diseases","year":2000,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Cardiac Ischemia and Reperfusion","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University","funders":"","keywords":"Medicine; Myocardial infarction; Cardiology; Internal medicine; Clinical trial; Placebo; Coronary artery disease; Thrombolysis; Pharmacology","authors":[{"name":"Morris Karmazyn","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07327883999910648,"gpt":0.4473595719300431,"spread":0.3740807319309366,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002338828,0.0007966837,0.001221932,0.0007055044,0.000368567,0.001089216,0.0007988868,0.00152117,0.005381206],"category_scores_gemma":[0.00131241,0.0002361153,0.0007041183,0.0005644748,0.0004267498,0.0005719551,0.0002762577,0.001953611,0.001463754],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005418207,"about_ca_system_score_gemma":0.001283793,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006718337,"about_ca_topic_score_gemma":0.001724046,"domain_scores_codex":[0.9994216,0.000280004,0.00005556383,0.00006187206,0.0001191472,0.00006188751],"domain_scores_gemma":[0.9992622,0.0001435908,0.0001681228,0.00004403993,0.0001767157,0.0002054441],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.02687106,0.00937397,0.004282468,0.00297368,0.0004372144,0.0009178518,0.0002133727,0.0008454054,0.1467543,0.002148738,0.006932106,0.7982498],"study_design_scores_gemma":[0.05220665,0.4781047,0.08469094,0.00183563,0.001876675,0.006956059,0.0003743422,0.002767265,0.06451872,0.002964124,0.3034628,0.0002422099],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.4031236,0.5132673,0.008853459,0.01028217,0.00115777,0.003947573,0.00185277,0.0004404589,0.05707499],"genre_scores_gemma":[0.698076,0.260238,0.0124424,0.008336561,0.002454326,0.0024749,0.002767013,0.00008265289,0.01312811],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.005381206,"threshold_uncertainty_score":0.01800191,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2057495794","doi":"10.1517/13543784.2011.565329","title":"Brivanib alaninate for cancer","year":2011,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":39,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Cetuximab; Medicine; Pharmacodynamics; Pharmacology; Cancer; Regorafenib; Angiogenesis; Colorectal cancer; Pharmacokinetics; Oncology; Internal medicine","authors":[{"name":"Iván Díaz-Padilla","is_ca":true},{"name":"Lillian L. Siu","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1165598438133721,"gpt":0.4131320326980932,"spread":0.2965721888847211,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002606088,0.0006111839,0.000581811,0.001063706,0.0002552088,0.0006860034,0.000604391,0.00105934,0.02348419],"category_scores_gemma":[0.0003214451,0.0001353713,0.0003576166,0.0008302602,0.0002571996,0.0005533322,0.000549705,0.001336466,0.02071229],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005144167,"about_ca_system_score_gemma":0.0005591345,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000599663,"about_ca_topic_score_gemma":0.001366601,"domain_scores_codex":[0.9998626,0.00002409397,0.00001082419,0.00002799762,0.00005341964,0.00002113895],"domain_scores_gemma":[0.9999142,0.00001755599,0.00002083299,0.000004144548,0.0000224307,0.0000208873],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001585448,0.00005030187,0.00007171223,0.003175507,0.00003353567,0.0003412135,0.00002510841,0.000125538,0.003183956,0.003089533,0.1119247,0.8778202],"study_design_scores_gemma":[0.00005546846,0.00007876856,0.0002160818,0.0004726875,0.0000172664,0.001239881,0.000007178648,0.00003203543,0.0008598668,0.000659858,0.9963551,0.000005908374],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0008614184,0.9499002,0.0006685265,0.003749992,0.002341228,0.00005129792,0.0002488008,0.0001444394,0.04203412],"genre_scores_gemma":[0.01182924,0.919319,0.0008882011,0.003970467,0.002450527,0.00008187187,0.0008192275,0.00002840409,0.06061308],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.02348419,"threshold_uncertainty_score":0.0785625,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2287387906","doi":"10.1517/13543784.2015.1083010","title":"An evaluation of RVX-208 for the treatment of atherosclerosis","year":2015,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"University of Calgary","funders":"","keywords":"Bromodomain; Apolipoprotein B; Mechanism (biology); Epigenetics; Pharmacology; Reverse cholesterol transport; Lipoprotein; Mechanism of action; Drug; Medicine; Cholesterol; Bioinformatics; Biology; Internal medicine; In vitro; Biochemistry; Gene","authors":[{"name":"Dragana Nikolić","is_ca":false},{"name":"Manfredi Rizzo","is_ca":false},{"name":"Dimitri P. Mikhailidis","is_ca":false},{"name":"Norman C.W. Wong","is_ca":true},{"name":"Maciej Banach","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.19381988199037,"gpt":0.4284758641484715,"spread":0.2346559821581015,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005114957,0.0005576608,0.0008838763,0.001478164,0.0001863485,0.0006063398,0.0005371241,0.0008659587,0.003713833],"category_scores_gemma":[0.0005193737,0.0001577551,0.0005292993,0.001069,0.0002578276,0.0006478393,0.000360044,0.001342629,0.001665452],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004491431,"about_ca_system_score_gemma":0.0007304091,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005612243,"about_ca_topic_score_gemma":0.001225471,"domain_scores_codex":[0.9998392,0.00003232598,0.00002488148,0.00002769088,0.00006076974,0.00001510032],"domain_scores_gemma":[0.9998176,0.00008111592,0.00003216669,0.000004043233,0.00005057216,0.000014651],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002155548,0.0000970511,0.0001066066,0.02008682,0.00009731189,0.0003122548,0.00005151092,0.0001928322,0.003431046,0.002534442,0.02223238,0.9506422],"study_design_scores_gemma":[0.0001022652,0.0004713358,0.001027331,0.006810821,0.0002483288,0.002598397,0.00005347427,0.000152063,0.002146698,0.001179208,0.9851854,0.00002477614],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003133722,0.9973183,0.0001134817,0.0003198447,0.0002376923,0.00001157399,0.00002714698,0.000006374948,0.001652258],"genre_scores_gemma":[0.0020866,0.995813,0.0002621739,0.0004861004,0.0001590808,0.00001759665,0.00005052832,0.000002424515,0.001122523],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003713833,"threshold_uncertainty_score":0.01242405,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2416001425","doi":"10.1080/13543784.2016.1195808","title":"Investigational targeted therapies for the treatment of testicular germ cell tumors","year":2016,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Brentuximab vedotin; Clinical trial; Oncology; Internal medicine; Targeted therapy; Germ cell tumors; Sunitinib; Disease; Ifosfamide; Chemotherapy; Cancer; Lymphoma; Etoposide; Hodgkin lymphoma","authors":[{"name":"Christoph Oing","is_ca":false},{"name":"Christian Kollmannsberger","is_ca":true},{"name":"Karin Oechsle","is_ca":false},{"name":"Carsten Bokemeyer","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06552153533269944,"gpt":0.360707653935143,"spread":0.2951861186024436,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000680212,0.0005903178,0.001088887,0.002097096,0.0001827705,0.0007711768,0.0006883981,0.0008877009,0.005137483],"category_scores_gemma":[0.001001514,0.0001611941,0.0007411717,0.001838144,0.0003195805,0.0007701992,0.0005345109,0.001408119,0.001465129],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004857268,"about_ca_system_score_gemma":0.0009838336,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007152437,"about_ca_topic_score_gemma":0.001708442,"domain_scores_codex":[0.9997175,0.00006357415,0.00004646723,0.00003747953,0.0001120093,0.00002286398],"domain_scores_gemma":[0.9995288,0.0002339852,0.0001091013,0.00001069298,0.00009251096,0.00002491842],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008197709,0.00005606401,0.0001418115,0.04128285,0.0001925864,0.0001789687,0.0000514281,0.0002555161,0.001041428,0.00192879,0.02446893,0.9303196],"study_design_scores_gemma":[0.00005939517,0.000140502,0.0009195318,0.02212918,0.0005047006,0.001532536,0.00007284283,0.0001087559,0.0005257233,0.00157655,0.9724116,0.00001884501],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00005973054,0.9990859,0.00004546713,0.0001621831,0.000101051,0.000005174676,0.00001466047,0.000002785271,0.0005231194],"genre_scores_gemma":[0.0006076433,0.9987876,0.0001063072,0.0001561146,0.00008993043,0.000005860936,0.00002116149,7.685235e-7,0.0002246511],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.005137483,"threshold_uncertainty_score":0.01718658,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2160247377","doi":"10.1517/13543784.17.2.217","title":"The use of dexrazoxane for the prevention of anthracycline extravasation injury","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Chemotherapy-related skin toxicity","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba","funders":"Canada Research Chairs","keywords":"Dexrazoxane; Anthracycline; Cardiotoxicity; Extravasation; Doxorubicin; Epirubicin; Medicine; Daunorubicin; Pharmacology; Idarubicin; Chemotherapy; Internal medicine; Pathology; Cancer; Cyclophosphamide; Breast cancer","authors":[{"name":"Brian B. Hasinoff","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1877064176791583,"gpt":0.419788730279666,"spread":0.2320823126005077,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005003571,0.0004711647,0.001021387,0.001758567,0.0001577646,0.000445245,0.0005773588,0.0007153933,0.003454464],"category_scores_gemma":[0.0007671132,0.0001533248,0.0005107182,0.001379592,0.0002226498,0.0005734204,0.0001960594,0.000414113,0.0009483786],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003431488,"about_ca_system_score_gemma":0.0008208026,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007018543,"about_ca_topic_score_gemma":0.00153766,"domain_scores_codex":[0.9997521,0.00006493335,0.00005668722,0.00003509988,0.00007691682,0.00001427685],"domain_scores_gemma":[0.9995708,0.0001998822,0.0001261251,0.000008934865,0.00008005141,0.0000142383],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002102299,0.00008838018,0.0005714493,0.06176994,0.0002517105,0.0009944069,0.00008011163,0.0001790894,0.00872326,0.0008221327,0.00868096,0.9176283],"study_design_scores_gemma":[0.0002272375,0.001057527,0.009471173,0.02988445,0.001542754,0.02152638,0.0002789173,0.0002898921,0.01252323,0.001278726,0.9218664,0.00005340957],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003930697,0.9985362,0.00008136177,0.00009922319,0.00005745178,0.000007035511,0.0000112266,0.000002897776,0.0008114878],"genre_scores_gemma":[0.002700031,0.9964712,0.0002534331,0.0001260363,0.00005917497,0.000007976181,0.00001950343,7.639034e-7,0.0003619611],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003454464,"threshold_uncertainty_score":0.01155639,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2101906616","doi":"10.1517/13543784.16.10.1525","title":"Next-generation calcineurin inhibitors for ophthalmic indications","year":2007,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Ocular Diseases and Behçet’s Syndrome","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"National Institute for Nanotechnology","funders":"","keywords":"Calcineurin; Ciclosporin; Medicine; Tacrolimus; Pharmacology; Uveitis; Blepharitis; Transplantation; Ophthalmology; Immunology; Internal medicine","authors":[{"name":"Eddy Anglade","is_ca":false},{"name":"Randall W. Yatscoff","is_ca":true},{"name":"Robert T. Foster","is_ca":true},{"name":"Ulrich Grau","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2398880046859435,"gpt":0.4298117209830393,"spread":0.1899237162970958,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000588638,0.001007403,0.001255199,0.002318827,0.0002924691,0.0006957441,0.001033157,0.001345398,0.009069605],"category_scores_gemma":[0.0004898746,0.0002455352,0.000557347,0.00176171,0.0003584515,0.001184363,0.0005004515,0.001583436,0.006340249],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005087893,"about_ca_system_score_gemma":0.0007121714,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008162698,"about_ca_topic_score_gemma":0.002237321,"domain_scores_codex":[0.9997892,0.00003325716,0.00001917803,0.00002787988,0.0001100189,0.0000204646],"domain_scores_gemma":[0.9997867,0.00008728746,0.00003738666,0.000008344399,0.00005164533,0.00002866677],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009650042,0.0001600184,0.0001264788,0.006382646,0.00006738705,0.0005752445,0.00004346468,0.0003339824,0.003934151,0.001756267,0.03833232,0.9481915],"study_design_scores_gemma":[0.00006802071,0.000122539,0.0005286111,0.001002132,0.00006124588,0.002439574,0.00002474368,0.0001039928,0.0007784468,0.0007948673,0.994062,0.00001381337],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002678077,0.9950469,0.0003807948,0.0003786521,0.0003467448,0.00001674175,0.00002261204,0.00002148263,0.003518438],"genre_scores_gemma":[0.001404729,0.9945247,0.0006750926,0.0004425581,0.0003358481,0.00002543038,0.00007705492,0.000003949919,0.002510683],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.009069605,"threshold_uncertainty_score":0.03034079,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2122461299","doi":"10.1517/13543784.17.5.811","title":"Roflumilast: an oral, once-daily selective PDE-4 inhibitor for the management of COPD and asthma","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Phosphodiesterase function and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary; Foothills Medical Centre","funders":"","keywords":"Roflumilast; Medicine; COPD; Asthma; Intensive care medicine; Lung function; Internal medicine; Lung","authors":[{"name":"Stephen K. Field","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04072050588806207,"gpt":0.3306587140258579,"spread":0.2899382081377958,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005187616,0.0007082398,0.001460985,0.002515296,0.0002447326,0.0006026668,0.000895759,0.0010773,0.003967277],"category_scores_gemma":[0.0005447615,0.0001948434,0.0006230438,0.001883053,0.0002504722,0.0008729792,0.0003012938,0.0009359697,0.002066797],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005241663,"about_ca_system_score_gemma":0.0009879721,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009168521,"about_ca_topic_score_gemma":0.002044877,"domain_scores_codex":[0.9998176,0.00002964111,0.00003031335,0.00002702919,0.00007537925,0.00002025747],"domain_scores_gemma":[0.9997829,0.00007894418,0.000053416,0.000004281779,0.00005890364,0.0000217004],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001660772,0.00008038971,0.0001847188,0.02725581,0.0001493488,0.0005059993,0.00003958692,0.0001271298,0.003339436,0.000499555,0.01808527,0.9495667],"study_design_scores_gemma":[0.0002459709,0.0005717408,0.003268732,0.01120719,0.0007348624,0.009157599,0.0001134134,0.0001796336,0.002775765,0.0008896485,0.9708095,0.0000459576],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002103909,0.9983572,0.0000937342,0.0002341402,0.0001549025,0.00001064266,0.00001811964,0.000007641085,0.000913182],"genre_scores_gemma":[0.001195525,0.9973802,0.0002354441,0.0002316741,0.0001658377,0.00001418722,0.00004306295,0.000001157547,0.0007329478],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003967277,"threshold_uncertainty_score":0.01327187,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2997288603","doi":"10.1080/13543784.2020.1709822","title":"Phase I/II parallel double-blind randomized controlled clinical trial of perispinal etanercept for chronic stroke: improved mobility and pain alleviation","year":2020,"lang":"en","type":"article","venue":"Expert Opinion on Investigational Drugs","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"","keywords":"Etanercept; Medicine; Physical therapy; Placebo; Stroke (engine); Visual analogue scale; Randomized controlled trial; Chronic pain; Clinical trial; Chronic stroke; Physical medicine and rehabilitation; Rehabilitation; Internal medicine; Tumor necrosis factor alpha","authors":[{"name":"Stephen J. Ralph","is_ca":false},{"name":"Andrew Weissenberger","is_ca":false},{"name":"Ventzislav Bonev","is_ca":false},{"name":"Liam King","is_ca":false},{"name":"Mikaela D. Bonham","is_ca":false},{"name":"Samantha Ferguson","is_ca":false},{"name":"Ashley Smith","is_ca":true},{"name":"Adrienne A. Goodman-Jones","is_ca":false},{"name":"Anthony Espinet","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1003967417263509,"gpt":0.3981617017785402,"spread":0.2977649600521893,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00310689,0.003478535,0.006232331,0.0009320363,0.0009896047,0.001724934,0.001883682,0.00353391,0.02250708],"category_scores_gemma":[0.002921848,0.001342391,0.001969101,0.0008630941,0.00212248,0.001985114,0.0005568442,0.003522997,0.004167131],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001202873,"about_ca_system_score_gemma":0.002794817,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001201098,"about_ca_topic_score_gemma":0.003211817,"domain_scores_codex":[0.9986387,0.0005293148,0.0001157666,0.0003070586,0.0001433677,0.0002659196],"domain_scores_gemma":[0.9987651,0.0002226588,0.0003170583,0.0001331338,0.000169906,0.0003921741],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9750753,0.01064442,0.0001350694,0.001337271,0.0005123232,0.00002640149,0.00003578941,0.0001755276,0.001993558,0.0001514778,0.001435873,0.008476812],"study_design_scores_gemma":[0.9795702,0.01941117,0.00020816,0.00002553607,0.00008417413,0.000008688027,0.000005524522,0.0001037284,0.00009842483,0.00008817184,0.0003903268,0.000005942874],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7057937,0.01394433,0.007699357,0.003078019,0.004095881,0.2393761,0.01236018,0.001567957,0.01208439],"genre_scores_gemma":[0.6625207,0.00820019,0.01145713,0.005417111,0.002063384,0.2833356,0.005047166,0.0001810228,0.02177762],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02250708,"threshold_uncertainty_score":0.07529366,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2002307343","doi":"10.1517/13543784.2011.549125","title":"AMG 386: profile of a novel angiopoietin antagonist in patients with ovarian cancer","year":2011,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Alberta Cancer Foundation; Amgen (Canada)","funders":"","keywords":"Angiopoietin 2; Ovarian cancer; Medicine; Angiogenesis; Malignancy; Cancer; Oncology; Antagonist; Internal medicine; Disease; Tumor progression; Overall survival; Cancer research; Receptor; VEGF receptors; Vascular endothelial growth factor","authors":[{"name":"Ewan J.D. Robson","is_ca":true},{"name":"Prafull Ghatage","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0426732515451642,"gpt":0.3193840067145453,"spread":0.276710755169381,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002834993,0.0001594377,0.0003834742,0.0001580931,0.00007668117,0.0002988797,0.0001346725,0.0002654542,0.002523796],"category_scores_gemma":[0.0005654775,0.00004156502,0.0002374093,0.0002124356,0.00005837666,0.0001862146,0.0001090751,0.0005049136,0.0004741803],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002162991,"about_ca_system_score_gemma":0.0002405479,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001945857,"about_ca_topic_score_gemma":0.00070241,"domain_scores_codex":[0.9999081,0.00002781902,0.000009532707,0.00001392622,0.00002780019,0.00001290678],"domain_scores_gemma":[0.9998642,0.00004183979,0.00004135735,0.00000257367,0.00002527341,0.0000247386],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.006183188,0.0002781643,0.01100314,0.00357144,0.0004612062,0.0006846666,0.0001168473,0.001070359,0.03310287,0.0009409265,0.01947145,0.9231157],"study_design_scores_gemma":[0.006520397,0.04152134,0.1094201,0.003253761,0.002654071,0.01330229,0.000333749,0.003505016,0.02481655,0.003455224,0.7911133,0.0001042655],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.2230813,0.7505119,0.001409532,0.004514213,0.000523811,0.0002495646,0.001426592,0.00009793392,0.01818512],"genre_scores_gemma":[0.7009467,0.2798055,0.003116535,0.005023862,0.0008484905,0.0002798121,0.002774592,0.00003132377,0.007173276],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002523796,"threshold_uncertainty_score":0.008442998,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2069838467","doi":"10.1517/13543784.12.1.65","title":"Recent developments in the psychobiology and pharmacotherapy of depression: optimising existing treatments and novel approaches for the future","year":2003,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Treatment of Major Depression","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre for Addiction and Mental Health","funders":"","keywords":"Monoaminergic; Major depressive disorder; Tricyclic; Neuroscience; Psychology; Antidepressant; Monoamine neurotransmitter; Medicine; Psychiatry; Pharmacology; Psychotherapist; Serotonin; Mood; Receptor; Internal medicine","authors":[{"name":"Peter Farvolden","is_ca":true},{"name":"Sidney H. Kennedy","is_ca":false},{"name":"Raymond W. Lam","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2784800403397673,"gpt":0.4347821196305606,"spread":0.1563020792907933,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001637132,0.0006880564,0.001160274,0.0009535498,0.0002843422,0.001187365,0.000952503,0.002039619,0.00525231],"category_scores_gemma":[0.001033716,0.0002253143,0.0005060997,0.001137579,0.0005796255,0.002405911,0.0006033962,0.001973633,0.002496724],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008038699,"about_ca_system_score_gemma":0.001504623,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008887334,"about_ca_topic_score_gemma":0.00246751,"domain_scores_codex":[0.9995959,0.0001374303,0.00006432676,0.00005319572,0.0001162773,0.00003275903],"domain_scores_gemma":[0.999293,0.0003285542,0.00009083874,0.00002742999,0.0001884544,0.00007171612],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001679,0.0001266246,0.0001850544,0.0104374,0.00006529668,0.0003425895,0.00008364501,0.0006688643,0.002157484,0.004669924,0.02366837,0.9574268],"study_design_scores_gemma":[0.0001232425,0.0004037032,0.001854373,0.005920354,0.0002113039,0.002281052,0.0002858638,0.0008461942,0.0008069549,0.009824782,0.9774,0.00004228319],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00027653,0.9933023,0.0007795161,0.003446033,0.0005387514,0.00001007614,0.000009684049,0.00001817222,0.001618896],"genre_scores_gemma":[0.001923885,0.9919295,0.002389442,0.001496851,0.001106342,0.00001580628,0.00002431903,0.000003473841,0.001110352],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00525231,"threshold_uncertainty_score":0.01757067,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2732154709","doi":"10.1080/13543784.2017.1349753","title":"Alicaforsen for the treatment of inflammatory bowel disease","year":2017,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Robarts Clinical Trials; Western University","funders":"","keywords":"Medicine; Pouchitis; Inflammatory bowel disease; Vedolizumab; Ulcerative colitis; Placebo; Clinical trial; Gastroenterology; Internal medicine; Crohn's disease; Disease; Immunology; Pathology","authors":[{"name":"Vipul Jairath","is_ca":true},{"name":"Reena Khanna","is_ca":true},{"name":"Brian G. Feagan","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1765178096892389,"gpt":0.4477101717914101,"spread":0.2711923621021711,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003971408,0.0006517516,0.0009438291,0.001666188,0.0001969351,0.0007253782,0.0005660747,0.0009191674,0.009494068],"category_scores_gemma":[0.0005574795,0.0001485237,0.0005398474,0.001239269,0.0002913334,0.0007671915,0.0005296547,0.001679004,0.005176856],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003914651,"about_ca_system_score_gemma":0.0006413336,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005937311,"about_ca_topic_score_gemma":0.001133069,"domain_scores_codex":[0.9997891,0.00003889024,0.00002808761,0.00003818174,0.00008690144,0.0000188963],"domain_scores_gemma":[0.9998154,0.00006313909,0.00004444809,0.000006067596,0.00005023955,0.00002067825],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.00009928879,0.00005662422,0.000084647,0.01856745,0.0001118175,0.0001423078,0.00004310826,0.0001877874,0.002441378,0.002538584,0.04438335,0.9313437],"study_design_scores_gemma":[0.00004107114,0.00009157652,0.000345445,0.00337885,0.0001111165,0.0008132105,0.00002186729,0.00004512555,0.0003907528,0.00104721,0.9937033,0.00001048789],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001321886,0.9966617,0.0001270943,0.0004403929,0.0004307296,0.00001352676,0.00004292716,0.00001289824,0.002138606],"genre_scores_gemma":[0.001139348,0.9960962,0.0002231655,0.0004864242,0.0003115962,0.00001523335,0.0000885257,0.000002976097,0.001636636],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.009494068,"threshold_uncertainty_score":0.03176081,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2905977615","doi":"10.1080/13543784.2019.1559295","title":"Rapastinel - an investigational NMDA-R modulator for major depressive disorder: evidence to date","year":2018,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Treatment of Major Depression","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Major depressive disorder; Antidepressant; Treatment-resistant depression; Adverse effect; Investigational Drugs; Clinical trial; Medicine; Depression (economics); Psychiatry; Meta-analysis; Cognition; Psychology; Pharmacology; Internal medicine; Anxiety","authors":[{"name":"Renee‐Marie Ragguett","is_ca":true},{"name":"Carola Rong","is_ca":true},{"name":"Kevin Kratiuk","is_ca":false},{"name":"Roger S. McIntyre","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1509173299690087,"gpt":0.4258168455622502,"spread":0.2748995155932416,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009460584,0.0006419996,0.001751896,0.001320431,0.0001869064,0.001044702,0.0009409448,0.001169078,0.006483184],"category_scores_gemma":[0.002513452,0.0002316413,0.00112839,0.00159915,0.0003260165,0.0008479645,0.0004195837,0.001070166,0.001430412],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004938272,"about_ca_system_score_gemma":0.001287863,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009240046,"about_ca_topic_score_gemma":0.002216427,"domain_scores_codex":[0.9996421,0.00008238057,0.00009312535,0.00005700211,0.0001022053,0.00002315952],"domain_scores_gemma":[0.9986989,0.0007459253,0.0003163665,0.00001941694,0.0001836131,0.00003578707],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003592868,0.00005057384,0.0002121192,0.1800345,0.0006505577,0.0001452831,0.0000591866,0.0001771982,0.0008696155,0.001220765,0.01924905,0.7969718],"study_design_scores_gemma":[0.0003606205,0.0006427144,0.002948094,0.171085,0.006356408,0.002292372,0.0001850216,0.0002359783,0.001318522,0.002264665,0.8122608,0.00004982402],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001014439,0.9991829,0.00003199167,0.0001905722,0.00006451719,0.000006538775,0.00002739414,0.000003314594,0.0003913419],"genre_scores_gemma":[0.00129766,0.9980879,0.0001053473,0.0002327375,0.00006576736,0.00001076393,0.00003357966,0.000001182476,0.0001650408],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.006483184,"threshold_uncertainty_score":0.02168846,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2539921642","doi":"10.1080/13543784.2016.1254187","title":"Lomitapide for the treatment of hypertriglyceridemia","year":2016,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University","funders":"","keywords":"Hypertriglyceridemia; Medicine; Microsomal triglyceride transfer protein; Acute pancreatitis; Triglyceride; Clinical trial; Intensive care medicine; Familial hypercholesterolemia; Internal medicine; Cholesterol; Lipoprotein","authors":[{"name":"Amanda J. Brahm","is_ca":true},{"name":"Robert A. Hegele","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1063324971780795,"gpt":0.4006755904027068,"spread":0.2943430932246274,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003807015,0.0004150245,0.0008332792,0.001480149,0.0001698238,0.0006233419,0.0005683445,0.0008257465,0.005837129],"category_scores_gemma":[0.0006427474,0.000133767,0.0005515618,0.000967839,0.000282491,0.0006916605,0.0003839963,0.001254191,0.002209563],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003057282,"about_ca_system_score_gemma":0.0005806825,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005618717,"about_ca_topic_score_gemma":0.001326892,"domain_scores_codex":[0.9998276,0.00003634427,0.00003046441,0.00002926444,0.00006307372,0.00001317137],"domain_scores_gemma":[0.9997709,0.00009374062,0.00006482723,0.000005150529,0.00005047416,0.00001476183],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001348554,0.00004654477,0.0001777359,0.03019704,0.0001698752,0.0003662074,0.0000572671,0.0001318393,0.001500855,0.00175776,0.04335552,0.9221045],"study_design_scores_gemma":[0.00008863199,0.0001354626,0.001089813,0.01490506,0.0003613851,0.004383922,0.00006714238,0.00009869243,0.0008207406,0.001413064,0.9766142,0.00002185055],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001781784,0.9971843,0.0000839156,0.0006335104,0.0002791766,0.00001011746,0.00003026184,0.000006970339,0.001593505],"genre_scores_gemma":[0.00173932,0.9961384,0.0001704582,0.000749815,0.0002690584,0.00001043521,0.00005480691,0.000001907591,0.0008657839],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.005837129,"threshold_uncertainty_score":0.0195272,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2140368374","doi":"10.1517/13543784.15.11.1337","title":"Cholesterol absorption inhibitors as a therapeutic option for hypercholesterolaemia","year":2006,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Cholesterol and Lipid Metabolism","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Robarts Clinical Trials; Western University","funders":"","keywords":"Ezetimibe; Sterol O-acyltransferase; Medicine; Cholesterol; Microsomal triglyceride transfer protein; Pharmacology; Bile acid; Drug; Internal medicine; Lipoprotein; Very low-density lipoprotein","authors":[{"name":"John R. Burnett","is_ca":false},{"name":"Murray W. Huff","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07968378855267716,"gpt":0.3865278753482458,"spread":0.3068440867955687,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004690921,0.0008141377,0.001329929,0.001946653,0.000303578,0.0006823221,0.0006582591,0.001352914,0.006264756],"category_scores_gemma":[0.0003232407,0.0002100643,0.0004688011,0.001432713,0.0003995739,0.001067756,0.0003919896,0.001727077,0.004694779],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004227123,"about_ca_system_score_gemma":0.0005959762,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006196673,"about_ca_topic_score_gemma":0.001860432,"domain_scores_codex":[0.9998275,0.00003533875,0.00001908237,0.0000254654,0.00007721662,0.00001541076],"domain_scores_gemma":[0.9998922,0.00004299657,0.00001766595,0.000005133353,0.00002735008,0.00001470671],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001617822,0.000169779,0.000130058,0.008010649,0.00007464232,0.001003596,0.00007631847,0.0001942672,0.004865144,0.003727427,0.04313133,0.938455],"study_design_scores_gemma":[0.00009010538,0.0001740456,0.0006684015,0.001342491,0.00007265819,0.003694699,0.00004432341,0.00007615247,0.0005963727,0.001254234,0.9919727,0.00001378767],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002905108,0.9945539,0.0002496629,0.0006871369,0.0004282806,0.0000117444,0.00001491547,0.00001534477,0.003748531],"genre_scores_gemma":[0.001401934,0.993524,0.0005780201,0.0008255793,0.0004142972,0.00001877247,0.00003812885,0.000002971346,0.003196287],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.006264756,"threshold_uncertainty_score":0.02095765,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2122024610","doi":"10.1517/13543784.13.4.403","title":"Ximelagatran: the first oral direct thrombin inhibitor","year":2004,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hamilton Health Sciences; McMaster University Medical Centre","funders":"","keywords":"Ximelagatran; Direct thrombin inhibitor; Medicine; Discovery and development of direct thrombin inhibitors; Coagulation; Anticoagulant; Thrombin; Intensive care medicine; Warfarin; Pharmacology; Atrial fibrillation; Dabigatran; Internal medicine","authors":[{"name":"Mark Crowther","is_ca":true},{"name":"Jeffrey I. Weitz","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1352479400011735,"gpt":0.3960961936146366,"spread":0.2608482536134631,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002445816,0.0008032531,0.001155582,0.00171596,0.0002369647,0.0009464168,0.0006202683,0.001183745,0.007030978],"category_scores_gemma":[0.000375818,0.0001811984,0.0003380756,0.001753618,0.0002823023,0.0009404626,0.0004073595,0.0009191827,0.006692264],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005031746,"about_ca_system_score_gemma":0.001031276,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009159523,"about_ca_topic_score_gemma":0.001284168,"domain_scores_codex":[0.9998236,0.00002371996,0.00002007808,0.00002876999,0.00008501462,0.00001884674],"domain_scores_gemma":[0.9998888,0.00003207399,0.00002866292,0.000004605531,0.00002810861,0.00001780645],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009422496,0.00006495824,0.0002077173,0.01016393,0.00004923759,0.0005908431,0.00004162944,0.000121279,0.00284941,0.001459188,0.03551058,0.9488469],"study_design_scores_gemma":[0.0000392532,0.00010617,0.000794506,0.001861209,0.00006883412,0.004060621,0.00002651169,0.00003257807,0.00113167,0.000634548,0.9912351,0.000008966303],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002481163,0.9951775,0.0001365816,0.0003998207,0.0002936672,0.000009755236,0.00003195292,0.00001750827,0.003685093],"genre_scores_gemma":[0.001718396,0.9936277,0.0002413841,0.0003555656,0.0002845814,0.00001017351,0.00005134554,0.000002445068,0.00370853],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.007030978,"threshold_uncertainty_score":0.02352095,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2100830152","doi":"10.1517/13543784.17.11.1761","title":"Clazosentan: an endothelin receptor antagonist for treatment of vasospasm after subarachnoid hemorrhage","year":2008,"lang":"en","type":"article","venue":"Expert Opinion on Investigational Drugs","topic":"Intracranial Aneurysms: Treatment and Complications","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Subarachnoid hemorrhage; Endothelin receptor antagonist; Vasospasm; Medicine; Cerebral vasospasm; Endothelin receptor; Antagonist; Placebo; Clinical trial; Randomized controlled trial; Receptor antagonist; Anesthesia; Internal medicine; Receptor; Pathology","authors":[{"name":"R. Loch Macdonald","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04050734314660269,"gpt":0.3031468555725261,"spread":0.2626395124259234,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003486779,0.0002859258,0.0007669876,0.0003054575,0.0001600465,0.0002617115,0.0005015439,0.0007085188,0.002698291],"category_scores_gemma":[0.0003329253,0.00005902955,0.0002455029,0.0002652189,0.0001621675,0.0001698484,0.0001004645,0.0007125968,0.001136098],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002920347,"about_ca_system_score_gemma":0.0003436553,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003710286,"about_ca_topic_score_gemma":0.001648424,"domain_scores_codex":[0.9998997,0.00003225544,0.00001248084,0.000012965,0.00002497064,0.00001755944],"domain_scores_gemma":[0.9998993,0.00002187095,0.00003350581,0.000004331851,0.00001653211,0.00002450634],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.009266087,0.001457638,0.002783743,0.002376462,0.000283309,0.001834948,0.00007516239,0.0003586409,0.06559324,0.0008074902,0.01959142,0.8955719],"study_design_scores_gemma":[0.08507864,0.07737914,0.1254207,0.002136558,0.001756052,0.03307487,0.0003147039,0.004169066,0.1229481,0.003394138,0.5441495,0.0001786654],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.4095817,0.5357431,0.00555045,0.01302636,0.002232834,0.0008208491,0.000746848,0.0004818823,0.03181604],"genre_scores_gemma":[0.7475706,0.2246436,0.006649934,0.005645184,0.001576288,0.0003534804,0.001118183,0.00003573209,0.01240701],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002698291,"threshold_uncertainty_score":0.009026706,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2149879542","doi":"10.1517/13543784.15.5.507","title":"The potential of clusterin inhibiting antisense oligodeoxynucleotide therapy for prostate cancer","year":2006,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Clusterin in disease pathology","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"","keywords":"Clusterin; Prostate cancer; Prostate; Gene silencing; Cancer research; Medicine; Cancer; Apoptosis; Oncology; Internal medicine; Biology; Gene","authors":[{"name":"Hideaki Miyake","is_ca":false},{"name":"Isao Hara","is_ca":false},{"name":"Masato Fujisawa","is_ca":false},{"name":"Martin Gleave","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05709997216926325,"gpt":0.3872571996764856,"spread":0.3301572275072223,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000351545,0.0004945509,0.0006389594,0.001016211,0.0001768691,0.0004970491,0.0004385547,0.0005913281,0.001687739],"category_scores_gemma":[0.0002333974,0.0001207412,0.0002521423,0.0007159427,0.0002019008,0.0005809344,0.0002077184,0.0005289803,0.001158558],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000395565,"about_ca_system_score_gemma":0.0004873991,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005394259,"about_ca_topic_score_gemma":0.001457459,"domain_scores_codex":[0.9999098,0.00001592612,0.00001016505,0.00001572634,0.00004040401,0.000008019582],"domain_scores_gemma":[0.9999087,0.00003896774,0.00001576269,0.000002112827,0.00002416638,0.00001023677],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009644646,0.00006461341,0.0001998568,0.008757645,0.00007043125,0.0004834648,0.00007508966,0.0005580033,0.01496004,0.002323973,0.0148066,0.9576039],"study_design_scores_gemma":[0.00003390305,0.0002870231,0.0006944062,0.0008081565,0.000100911,0.002141308,0.00004880735,0.0001523117,0.004386213,0.0008188959,0.9905086,0.0000195112],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000680755,0.9965554,0.0004974923,0.000277019,0.0002739771,0.000007867895,0.00001090769,0.00001076966,0.001685853],"genre_scores_gemma":[0.002422433,0.9949192,0.0006311886,0.0002835082,0.0001897941,0.00001347435,0.00002871587,0.000002091021,0.001509449],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.001687739,"threshold_uncertainty_score":0.00564605,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2094081851","doi":"10.1517/13543784.2013.840289","title":"Investigational drugs for onychomycosis","year":2013,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Terbinafine; Medicine; Adverse effect; Drug; Dermatology; Drug development; Pharmacology; Clinical trial; Intensive care medicine; Antifungal; Itraconazole; Internal medicine","authors":[{"name":"Aditya K. Gupta","is_ca":true},{"name":"Fiona C. Simpson","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1200528077595505,"gpt":0.4104213781560894,"spread":0.2903685703965388,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003717855,0.0008087954,0.001154309,0.00220774,0.0002573232,0.0007986918,0.0008066783,0.001095141,0.01341837],"category_scores_gemma":[0.0005399095,0.0001851029,0.0006228084,0.001889576,0.0003693586,0.0008581047,0.0006190517,0.001766097,0.007087964],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005443616,"about_ca_system_score_gemma":0.0007760884,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007639028,"about_ca_topic_score_gemma":0.001826175,"domain_scores_codex":[0.9997346,0.00004309837,0.00002860089,0.00004105845,0.0001268929,0.00002577446],"domain_scores_gemma":[0.9997737,0.00007207536,0.00005410796,0.00000908472,0.00006762212,0.00002346901],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006590525,0.00006798816,0.00007718409,0.01457844,0.00007290552,0.0003091344,0.00003695381,0.000169065,0.002060832,0.002645611,0.05811447,0.9218014],"study_design_scores_gemma":[0.00002540118,0.00006249491,0.0002712962,0.002879116,0.0000653653,0.001231276,0.00002011642,0.00004735885,0.0003628451,0.0008448427,0.9941807,0.000009110319],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001438735,0.9937382,0.0001899309,0.0004548846,0.0005359293,0.00001962688,0.00005837863,0.00001871346,0.004840394],"genre_scores_gemma":[0.001236303,0.9944463,0.0003633469,0.000574533,0.0003616973,0.00001940688,0.0001081931,0.000003615243,0.002886542],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01341837,"threshold_uncertainty_score":0.04488891,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}